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 The harm caused to a host (virulence) is an important aspect to any pathogenic 
infection and is influenced by many different factors. Here I seek to understand how three 
of these factors, host genetic diversity, transmission, and gut microbial diversity, 
influence the virulence of a murine specific retrovirus, Friend Virus Complex (FVC). 
Chapter 1 explores the effect of major histocompatibility complex (MHC) diversity on 
virulence. Using serial passage of FVC, through either MHC similar or MHC dissimilar 
mice, I show that there is a significant reduction of both fitness and virulence of FVC 
when a dissimilar genotype is seen than when FVC is passaged through the same 
genotype; suggesting that MHC diversity is an impediment to virulence evolution. 
Furthermore, the alternating patterns reemerged after infection with a virus adapted to 
resistant animals that initially swamped the alternating effect, providing evidence for 
negative frequency-dependent selection maintaining MHC diversity in host populations. 
Chapter 2 elucidates the influences natural transmission, sex, and social status have on 
virulence using wild-derived contact (initially uninfected) and index (initially infected) 
animals in seminatural enclosures. Male-male transmission is the predominant mode of 
transmission as minimal female transmission and no vertical transmission was observed. 
Moreover, natural transmission is an impediment to FVC replication as infected contact 
animals had lower viral titer and virulence than index animals. Finally, though dominant 
and nondominant males contract the virus at similar rates and experience similar 
iv 
virulence, nondominant animals have higher titers. Chapter 3 seeks to understand how the 
microbiome influences pathogen virulence. After antibiotic treatment, animals of two 
different MHC congenic genotypes were reconstituted with gut microbiota from a donor 
of their own MHC genotype (native) or from a donor with a different MHC genotype 
(novel). After challenge with FVC, significantly higher titers were seen in animals 
receiving novel microbiota than animals receiving native microbiomes. There was only a 
shift down in total T-lymphocyte number in novel groups as no other cell subsets tested 
showed a change in abundance. The work presented here allows us to gain a better 
understanding of how virulence is impacted by a multitude of different forces, and that 
many different aspects need to be taken into account when trying to determine the 
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Virulence is an important component of any pathogenic infection, as it is the harm 
caused to the host by the pathogen. Moreover, there are many factors that lead to 
virulence, or lack of virulence, within a host; however, many of these components are 
still unknown or do not have sufficient testing in the literature (Alizon et al., 2009). 
Genetic diversity in a host population, transmission patterns, and most recently, microbial 
diversity have all been suggested to control virulence of pathogens and are the focus of 
this dissertation (Ebert & Bull, 2008; Koch & Schmid-Hempel, 2012; Buffie & Pamer, 
2013). Conversely, the evolutionary pressures leading to virulence have also been 
thought to influence diversity in host populations through antagonistic interactions 
between host and pathogen (Salathé et al., 2008; Brockhurst et al., 2014).   
Since the discovery of the major histocompatibility complex (MHC) in the late 
1940s, there has been strong interest in the unprecedented genetic diversity found at the 
classic peptide-antigen presenting genes within the complex (Snell, 1948). JBS Haldane 
hypothesized that the purpose of the diversity of these cell surface proteins may be to 
combat the constant barrage of infectious pathogens (Haldane, 1949). Haldane’s 
hypothesis was later refined and dubbed the Red Queen (RQ) hypothesis (Van Valen, 
1973; Bodmer et al., 1986). The RQ hypothesizes that as pathogens adapt to a single 
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host, they become more specialized on that host genotype. It follows that those pathogens 
will then have a more difficult time replicating in hosts with dissimilar host genotypes. 
Through these interactions, and with varying amounts of allele frequencies in host 
populations, rare beneficial alleles (initially derived through mutations) will rise in 
frequency due to the decline of common alleles to which pathogens are adapting. This 
cyclical process is termed frequency-dependent selection and is one hypothesis for how 
MHC diversity is maintained in host populations (Apanius et al., 1997; Sutton et al., 
2011; Brockhurst et al., 2014). 
During MHC-specific RQ coevolution, the pathogen has a selective advantage 
when mutations that abolish MHC binding to a particular peptide occur. However, if 
there are more alleles capable of recognizing a higher number of viral peptides and these 
alleles are distributed throughout a population, this MHC diversity can contribute to 
counteracting the viral fitness advantage; because escape from one allele does not mean 
escape from all alleles (Finlay & McFadden, 2006). Classical MHC genes have been 
shown to be associated with pathogen load, where an increased number of alleles in a 
host population correlates with a lower number of parasites and pathogens affecting that 
population (Jeffery & Bangham, 2000; Radwan et al., 2010). Furthermore, serial passage 
studies have shown that the two main tenets of the RQ hold true: genotype specific 
adaption occurs and there is a tradeoff in pathogen virulence when new genotypes are 
seen (Ebert, 1998; Kubinak et al., 2012, 2013). MHC diversity in a population has also 
been suggested to have a major role in defense against pathogen adaptation (Kubinak et 
al., 2013). Nonetheless, it is still unknown how rapid this host genotype specific 
adaptation is and to what extent MHC plays a role when adaptation time is limited, as 
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when a pathogen is moving through a population.  
The vertebrate immune system consists of two different, but interconnected 
responses, the innate and adaptive. Innate immune responses consist of an immediate 
broad response to the foreign invader, usually within a few hours of infection (Abbas et 
al., 2012). The adaptive response, on the other hand, is a highly specific response usually 
driven by T-lymphocyte recognition of MHC presenting a foreign peptide (protein 
segments that have been degraded by cellular machinery) (Germain, 1994). After 
intracellular binding of MHC to a peptide, the MHC-peptide complex is presented on the 
outside of the cell to be interrogated by circulating T-lymphocytes (T-cells). Following 
recognition by a T-cell receptor (TCR), that T-cell clonally proliferates and becomes 
activated for cytopathic activities, allowing for recognition and destruction of other cells 
presenting the same MHC-peptide complex (Watts, 1997). If a viral pathogen mutates 
part of the peptide that the MHC molecule is binding (anchor positions), it will not be 
presented and will therefore escape immune recognition through that foreign peptide, 
usually leading to an increase in viral fitness (Finlay & McFadden, 2006).  
The studies in this dissertation utilize Friend Virus Complex (FVC) as a mouse-
specific pathogen to test various hypotheses concerning factors that influence virulence 
evolution. FVC is a murine specific gamma retrovirus that preferentially infects dividing 
erythroblasts, leading to enlargement of the spleen and liver (Friend, 1957). Given that 
one site of FVC replication is the spleen, it is ideal to use for serial passage studies as it is 
easily titered and passaged. FVC is referred to as a complex because it consists of two 
viral genomes that work together synergistically to cause disease. The first genome, 
Friend Murine Leukemia Virus (F-MuLV) is a replication competent retrovirus that can 
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complete its entire life cycle independent of other genomes or pathogens (Hasenkrug & 
Chesebro, 1997). Spleen Focus Forming Virus (SFFV), on the other hand, cannot 
complete its life cycle without the help of F-MuLV, as the envelope of the F-MuLV 
complements SFFV and allows SFFV to exit the cell. Though SFFV cannot produce the 
necessary proteins that allow it to form a capsid and exit the cell, it can stimulate the 
erythropoietin receptor and causes uncontrolled proliferation of the infected erythroblast 
(Ruscetti, 1999). In this way, SFFV creates more target cells for F-MuLV, which in turn 
complements SFFV, allowing for a synergistic interaction that leads to higher fitness for 
both viral genomes.  
 Inbred laboratory mice are powerful tools to understand how pathogen virulence 
is influenced by a multitude of factors. MHC congenic strains are identical throughout the 
entire genome with the exception of the three megabase gene region of the MHC. 
Utilizing three strains of MHC congenic mice (Balb/cdd, Balb/ckk, and Balb/cbb) allowed 
interrogation of the relationship between MHC, pathogen adaptation, and the influence of 
gut microbiota on virulence. Though inbred congenic animals are a powerful tool in 
controlled laboratory settings, they do not allow for natural transmission of FVC at a 
level useful for experimentation, due to impaired functional behaviors (Nelson et al., 
2013; Chalfin et al., 2014). Therefore, I also utilized wild-derived mice that engage in 
natural behaviors when placed in seminatural enclosures (Potts et al., 1991; Meagher et 
al., 2000; Ruff et al., 2012). Wild-derived mice were useful in understanding the natural 
history of FVC, as well as allowing investigation of how natural transmission influences 
virulence of FVC.  
This dissertation tests three hypotheses related to the virulence of a murine 
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retrovirus. First, if diversity throughout the genome is capable of impeding pathogen 
virulence in just one round, it follows that a single alternation of an MHC host genotype 
will impede FVC fitness and virulence when compared to a passage occurring through 
the same MHC host genotype due to its role in virulence evolution (Kubinak et al., 2013, 
2015a). The second set of hypotheses regard how natural transmission, host sex and 
social status influence virulence of FVC. FVC is thought to be transmitted through bodily 
fluids (Mirand et al., 1966; Portis et al., 1987), suggesting there may be differential 
transmission efficiency between the sexes with males transmitting more due to their 
antagonistic encounters. In addition, natural transmission barriers are expected to reduce 
overall rates of virulence evolution of FVC relative to investigator transmission. The 
third hypothesis regards microbiome diversity. It has been recently shown that MHC 
genotype sculpts the composition of the host gut microbiota and that transferring 
microbiota between two animals can shift susceptibility to enteric pathogens (Stecher et 
al., 2005; Kubinak et al., 2015b). Furthermore, transferring gut microbiome causes 
changes in some immune cell subsets (Cebra et al., 1998; Mazmanian et al., 2005; Zaph 
et al., 2008; Hensley-McBain et al., 2016). These findings suggest two possible 
hypotheses; (1) when gut microbiota is transferred between two different individuals with 
differing MHC genotypes there will be an increase in virulence of a systemic pathogen, 
such as FVC, due to a energetics resource tradeoff occurring within immune system 
because the novel transplant contains many new antigens that may be responded to 
hindering the ability of a systemic immune response, or (2) microbiota will interact with 
the host immune system as it did in the original host leading to susceptibility shifts that 
correspond with the resistance of the donor host. Microbial transfers have large 
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implications in human health as the recent literature has shown them to be successful in 
treatment of some enteric pathogens (Bakken et al., 2011); however, it is still unknown 
what other physiological effects occur when there are changes in the gut microbiome. 
 
1.1 Chapter Summaries 
1.1.1 Chapter 2 
The MHC is the most genetically diverse region in the vertebrate genome with 
over 2,500 Class I alleles known in the human population alone (Robinson et al., 2015). 
The MHC region is vitally important in immunity due to its capability to recognize 
foreign peptides (Germain, 1994). It has been suggested that increased allelic diversity of 
MHC in host populations can have a negative influence on the presence of pathogenic 
infection and that there only needs to be one host change between two different 
genotypes to see this negative effect (Brockhurst et al., 2014; Kubinak et al., 2015a). In 
this chapter, I test the hypothesis that when FVC is passaged through hosts with 
alternating MHC genotypes, there will be a reduction in fitness and virulence compared 
to viruses passaged through a single host genotype (pure passage). These pure passages 
consisted of FVC being serially passaged three times through a series of genetically 
identical mice. The alternated passages consisted of FVC being serially passaged through 
three rounds of mice, but with a different MHC genotype in the second round. This 
protocol allowed determination of the effect of a single MHC genotype change on 
virulence evolution of FVC. There is a significant reduction in both fitness and virulence 
when the virus is passed through an alternating genotype, leading to the conclusion that 
increased MHC diversity is an impediment to pathogen adaptation, as exposure to just 
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one new MHC genotype can significantly hinder viral adaptation. 
Due to the resistance of one of the MHC genotypes, I was also able to test the 
hypothesis that negative frequency-dependent selection is one possible mechanism by 
which MHC diversity is maintained in host populations. Initially, the resistant MHC 
genotype did not show the predicted effect of lower viral fitness and virulence when the 
virus was passed through alternating hosts; which may be due to the inherent resistance 
masking the reduction in fitness and virulent seen when MHC alternating passages are 
done because the resistance keeps the virus from replicating. To test this hypothesis, I 
modified the resistance of this MHC by using a strain of FVC that had been given the 
opportunity to adapt to the resistant genotype over ten rounds of passage. Using the 
adapted FVC virus allowed me to see a significant reduction in both fitness and virulence 
when the virus was passed through a dissimilar genotype, exactly what one would expect 
if negative frequency-dependent selection was occurring in the experimental population. 
 
1.1.2 Chapter 3 
Transmission is an important aspect of life history for any natural pathogen, as it 
is the process required for pathogen propagation (Antonovics et al., 2017; Mccallum et 
al., 2017). In order to determine the influence transmission, host sex and social status 
have on virulence, I used wild-derived animals in seminatural enclosures. The 30 m2 
enclosures allowed the mice to interact naturally, leading to competition for mates and 
territories between the males and selective mate choice by females (Potts et al., 1991; 
Carroll & Potts, 2007). Since FVC is believed to transmit through bodily fluids, the 
natural behavior witnessed in the seminatural enclosures promotes transmission of the 
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virus through increasing interactions between mice. To test the hypotheses that males are 
the main source of transmission, that natural transmission hinders virulence and that 
social status can influence virulence, three different infection-treatment populations were 
created using both index (infected) and contact (initially uninfected) animals. The three 
treatments were: female only index, male only index, and both female and male index 
populations. This design allowed me to determine the relative transmission frequencies 
via each sex. Furthermore, by measuring the virulence and titer of FVC in each contact 
animal, I was able to determine how natural transmission affected virulence relative to 
the experimentally infected index animals.  
I found that populations that have both male and female index animals, or male 
only index animals have the highest rates of transmission, whereas the populations with 
only females have the lowest rates of transmission. These results suggest that males are 
the main source of transmission events in this system.  Even though there was a 
significant increase in viral titers in male contact animals compared to female contact 
animals, the higher rates of transmission did not lead to increased spleen mass in males 
over females. Not only are males transmitting the virus more, but they are also harboring 
more virus per unit of spleen after contracting the virus, providing evidence that FVC 
may be male adapted. Moreover, as natural transmission occurs in these populations, 
there is a significant reduction in overall virulence of FVC in contact animals compared 
to index animals. Likewise, index animals had significantly higher titers than contact 






1.1.3 Chapter 4 
Fecal microbiome transfers (FMT) are showing promise in the treatment of 
enteric pathogens (Bakken et al., 2011; Vrieze et al., 2013). Though there have been 
many studies elucidating the effects of microbiome on enteric function, there has been 
little information published about how transferring the microbiome influences systemic 
immunity of the host (Sekirov et al., 2010). Using established microbial transfer methods 
with antibiotic treatment, followed by recolonization with new microbial constituents, 
one could inquire whether fecal transplants from different host genotypes influence 
systemic virulence (Kubinak et al., 2015b). I propose two hypotheses; (1) that due to a 
trade-off in immune function created when a host must respond to the new antigens 
present when encountering a novel microbiome, a systemic viral pathogen will have 
higher virulence than it would if the host had a native microbiome and (2) the resistance 
to FVC of the donor microbiome will be recapitulated in the host receiving the microbial 
transplant due to the cross talk between the gut microbiome and the host immune system. 
To test these hypotheses, I created both treatment (novel) and control (native) groups. In 
the treatment groups, novel microbiomes were transferred between two different MHC 
congenic mouse strains (Balb/cdd and Balb/cbb), while in the control groups each animal 
received native microbiome from a host with the same MHC genotype. Following 
reconstitution each animal was challenged with a stock FVC. 
The test resulted in virus from the novel treatment group having significantly 
higher titer and virulence than the native group, partially confirming hypothesis one. This 
may be due to an immune tradeoff where the host is shuttling more immune resources to 
the gut and the systemic compartment is left with fewer resources capable of responding 
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to the pathogen (Lochmiller & Deerenberg, 2000; Bordes & Morand, 2011). However, 
only a reduction of overall lymphocyte number was seen in cell immune phenotyping in 
novel groups and there were no other significant effects. This suggests that a wider 
variety of immune cell subsets need to be tested in order to fully understand how 
microbiome transfers influence susceptibility to systemic pathogens. The finding that 
fecal transplants increase susceptibility to pathogens has large implications in the human 
health field, as using this line of treatment for enteric pathogens may make the patient 
more susceptible to systemic infection. 
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EXPERIMENTAL MANIPULATION OF POPULATION-LEVEL  
MHC DIVERSITY CONTROLS PATHOGEN VIRULENCE  
EVOLUTION IN MUS MUSCULUS 
 
2.1 Abstract 
The virulence levels attained by serial passage of pathogens through similar host 
genotypes in laboratories are much higher than observed in natural systems, however, it 
is unknown what keeps natural virulence levels below these empirically demonstrated 
maximum levels. One hypothesis suggests that host diversity impedes pathogen 
virulence, because adaptation to one host genotype carries tradeoffs in the ability to 
replicate and cause disease in other host genotypes. To test this hypothesis, with the 
simplest level of population diversity within the loci of the major histocompatibility 
complex (MHC), we serially passaged Friend Virus Complex (FVC) through two rounds 
in hosts with either the same MHC genotypes (pure passage) or hosts with different MHC 
genotypes (alternated passage). Alternated passages showed a significant overall 
reduction of viral titer (41%) and virulence (55%) when compared to pure passages. 
Furthermore, a resistant host genotype initially overshadowed the effects we expected to 
see during alternating MHC passages, however, when FVC was allowed to adapt to the 
resistant host genotype, typical effects emerged in alternating lines, i.e., alternated lines 
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show reduced virulence. These data indicate serial exposure to diverse MHC genotypes is 
an impediment to pathogen adaptation, suggesting genetic variation at MHC loci is 
important for limiting virulence in a rapidly evolving pathogen and supports negative 
frequency-dependent selection as a force maintaining MHC diversity in host populations. 
 
2.2 Introduction 
Serial passage studies of pathogens have shown order-of-magnitude increases in 
virulence; however, many of the factors contributing to this virulence evolution are still 
unknown (Brown et al., 2001; Kawecki et al., 2012; Kubinak et al., 2013). Genotype 
specific adaptation by the virus may be a major cause of these order-of-magnitude level 
virulence increases, as each experimental passage was done through similar host 
genotypes. The hypothesis that between host genetic diversity can influence virulence 
was tested in a mouse-retrovirus system and when host genotypes are alternated during 
serial passage, trade-offs occur as both fitness and virulence evolution are severely 
impeded (Kubinak et al., 2015); this provides an explanation for why the virulence of 
pathogens in nature, seem to seldom reach the levels observed during serial passage 
studies in the laboratory. However, the previous study used mouse genotypes that 
differed across the entire genome, so that study was unable to identify any regions of 
particular importance for retarding virulence evolution. 
Classical major histocompatibility complex (MHC) genes are the most 
polymorphic loci known in vertebrates and play a critical role during immune recognition 
(Robinson et al., 2015).  The high degree of allelic diversity present in host populations is 
thought to be due to antagonistic coevolution between hosts and their pathogens (Potts et 
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al., 1994; De Boer et al., 2004). Often referred to as Red Queen (RQ) dynamics, these 
interactions predict reciprocal patterns of selection whereby adaptations that benefit one 
species will favor counter-adaptations in the interacting species (Van Valen, 1973). 
Furthermore, RQ dynamics may lead to maintenance of MHC diversity in populations 
through negative frequency-dependent selection; in turn, controlling virulence in the host 
population because of the trade-offs associated with genotype specific adaptation, i.e., 
specialization (Carius et al., 2001; Meyer-Lucht & Sommer, 2005; Sutton et al., 2011).  
MHC class I and class II genes allow for discrimination between self and nonself 
peptide antigens by encoding cell surface molecules that bind and present intracellular 
and extracellular peptides on the cell surface for interrogation by circulating T-
lymphocytes (T-cells) (Jeffery & Bangham, 2000; Wegner et al., 2003; Spurgin & 
Richardson, 2010). Recognition by a T-cell expressing a cognate T-cell receptor to a 
given MHC-peptide complex, with co-stimulating factors, triggers an adaptive immune 
response (Watts, 1997). Consequently, circumventing antigen presentation by MHC 
molecules may be a primary means by which pathogens increase within-host growth rates 
(fitness) (Fruh et al., 1999). For example, over 50% of genetic variants seen in Human 
Immunodeficiency Virus (HIV) occur in MHC presented epitopes (Pereyra et al., 2011; 
Henn et al., 2012); viral adaptation to escape specific MHCs could lead to trade-offs in 
pathogen fitness in hosts expressing different MHC molecules, due to the specialization 
of the viral pathogen on the first host leading to maladaptation in the second host. 
Multiple studies in mice have demonstrated that MHC polymorphisms influence the 
severity of disease associated with pathogen infection (i.e., virulence) (Meyer-Lucht & 
Sommer, 2005; Wedekind et al., 2006; Kubinak & Potts, 2013). Furthermore, trade-offs 
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in pathogen fitness associated with adaptation to specific MHC genotypes between 
multiple hosts may explain the association between virulence and MHC polymorphism 
(McClelland et al., 2003).  
Friend Virus Complex (FVC) is a mouse specific gamma-retrovirus that has been 
used extensively in immunological studies and more recently in experimental evolution 
studies (Kubinak et al., 2012b, 2013, 2015). The complex is made up of two viral 
genomes that work synergistically to cause an erythro-proliferative disorder in 
susceptible mouse strains: the replication-competent Friend Murine Leukemia Virus (F-
MuLV) and the replication-incompetent Spleen Focus Forming Virus (SFFV) (Friend, 
1957; Ruscetti, 1999). FVC has been shown to adapt to specific host MHC genotypes 
through serial passage, which results in a reduction of fitness and virulence when hosts 
possessing different MHC genotypes are encountered (Kubinak et al., 2012b). A recent 
study also suggests that loci within the MHC region account for a majority of the 
reduction in pathogen fitness and virulence associated with exposure to a novel host 
genotype (Kubinak et al., 2013); however, the previously mentioned studies were 
performed by serially exposing FVC to a single MHC genotype through ten rounds of 
passage, which is unlikely to happen in wild host populations because of existing genetic 
variation at these loci.   
Here we test the simplest case of a population where we alternate virus between 
two different host MHC genotypes to determine whether MHC polymorphisms between 
two individuals is sufficient to reduce viral fitness and virulence. We hypothesize that 
passage of FVC through two hosts possessing unique MHC alleles will result in 
significantly lower viral fitness and virulence than virus serially exposed to the same 
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MHC genotype. The work presented here builds upon previous evidence showing 
benefits of genome-wide genetic diversity and suggests that between-host MHC diversity 
may be a major factor reducing pathogen virulence while simultaneously  being 
maintained through selective pressures imposed by pathogens interacting with host 
genotypes (Kubinak et al., 2012b, 2013, 2015).  
 
2.3 Methods 
2.3.1 Mouse Model 
The Mus musculus animals used for the study were 2 to 6 month old females 
purchased from Jackson Laboratories and bred under specific-pathogen-free conditions. 
Three different MHC congenic strains of BALB/c mice were used: BALB/cByJ 
(Balb/cdd), C.C3-H2k (Balb/ckk), and C.B10-H2b (Balb/cbb). Each independent 
experiment consisted of three viral passage lines with ten replicates per line, followed by 
a test phase again using ten replicates per passage line. All of the strains used were 
susceptible to FV infection; however, they had different susceptibility profiles with 
BALB/cbb being most resistant, BALB/cdd being least resistant, and BALB/ckk being of 
intermediate resistance (Chesebro et al., 1990; Kubinak & Potts, 2013). All animals were 
housed and used in accordance with the University of Utah Institutional Animal Care and 
Use Committee (protocol # 04-08022). 
 
2.3.2 Pathogen Model 
A previously described biological clone of an NB-tropic strain of Friend Virus 
Complex (FVC) was maintained in an NIH3T3 fibroblast cell line (biological clone) and 
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used to generate all viral stocks used in the experiments (Kubinak et al., 2012b, 2013, 
2015; Kubinak & Potts, 2013). Unpassaged viral stocks were generated by harvesting 
viral cell supernatants from an infected NIH3T3 fibroblast cell line; this bioclone stock 
was passaged for two rounds through BALB/cdd animals in order to obtain a BALB/cdd 
adapted stock virus; furthermore, due to the high mutation rates and large population 
sizes viruses are known to have, this two round passage also increases viral diversity of 
the stock virus allowing evolution to act (Lauring & Andino, 2010; Domingo et al., 
2012). The two-round adapted stock was used to start all passage lines for each individual 
experiment, excluding the Balb/cbb adapted two round experiment. The two-round 
adapted stock was used to maintain sustained animal-to-animal passage in more resistant 
Balb/cbb and Balb/ckk genotypes. Spleen supernatants from the 14 animals infected in the 
second round were pooled in order to obtain enough volume to last the duration of the 
experiment. The pooled spleen supernatants were aliquoted and stored at -80°C. All viral 
stocks were kept on ice and each aliquot was only thawed once. 
 
2.3.3 Virulence Estimates 
FVC causes an erythro-proliferative disorder leading to gross enlargement of the 
spleen (splenomegaly) during acute infection.  Thus, disease virulence (harm to host) was 
quantified by measuring spleen mass to the nearest hundredth of a gram.  
 
2.3.4 Viral Fitness Estimates 
Viral titer (retroviral genomes integrated into the host genome) was used as a 
proxy for viral fitness.  Due to the correlated relationship between F-MuLV and SFFV (p 
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= 0.014, r2 = 0.41) we only F-MuLV titer data was fully generated (Figure 2S.1); 
however, SFFV titer data was also generated on a subset of the animals, showing a 
similar effect to F-Mulv (Figure 2S.2). Viral titer was measured by using the Roche 
Lightcycler 2.0 platform with primers previously published for this system (Kubinak et 
al., 2012b). Detected F-MuLV viral genomes were normalized to glyceraldehyde-3-
phospate dehydrogenase (GAPD) copies in order to get a standardized ratio of viral 
genomes per host genome copies. The viral genome by GAPD genome ratios were then 
multiplied by the spleen mass in order to obtain estimates of viral genomes per spleen. 
 
2.3.4 Serial Passage Design 
The initial passage rounds were created by using either a two-round Balb/cdd 
passaged stock virus or a Balb/cbb adapted stock virus (described below) to infect, 
through intraperitoneal (ip) injection, 10 individual animals of each mouse strain. At 12 
days postinfection each animal was sacrificed, infected spleens were collected for viral 
load estimates, and measurements of disease were made. After organ mass was recorded 
a portion of the spleen was saved in RNAlater™ and the rest combined in a 1:1 ratio of 
1x Phosphate Buffered Saline (PBS) (i.e., 1g of spleen was diluted in 1ml PBS).  The 
spleen-PBS mixture was mechanically homogenized. Homogenates were then 
centrifuged at 5000 RPM for 5 min and virus-laden supernatants were collected and 
frozen at -80oC. In order to control for dose of the virus in the test phase each viral 
inoculum was standardized by titering the supernatant and diluting it to the average titer 
of the alternating treatment group with the lowest average titer of its replicates; any 
inoculum under the average was used undiluted at a full dose (200uL) while anything 
21 
 
above the average was diluted before injection. Furthermore, it has been previously 
shown that there is no graft effect of viral proteins, from a previous animal seen, when 
the spleen supernatant is injected into a novel host (Kubinak et al., 2015). 
 
2.3.5 Stock Two-Round Alternating Experiments 
Experiments consisted of three independent sub-experiments carried out in each 
BALB/c MHC congenic mouse strain (Balb/cdd, Balb/ckk, and Balb/cbb). In each, virus 
was passaged twice through animals possessing the same MHC genotype or twice 
through animals possessing different MHC genotypes (Figure 2.1). 200 uL of the stock 
virus was used to inoculate 10 animals of each MHC congenic strain (Round 1). After the 
infection period, the animals were sacrificed and 20 uL of each individual spleen 
supernatant was used to infect an animal from each of the three MHC congenic host 
strains (Round 2). After the second infection period, the spleen supernatant was 
standardized and used to inoculate the original strain of passage (Test Phase). Three sub-
experiments were done in total with each congenic strain of Mus acting as the control 
pure passage with their corresponding alternated passage lines through the other two 
MHC genotypes. In total, there were 70 infections with 30 independent passage lines in 
each of the three subexperiments, for a total of 210 infections. 
 
2.3.5 Balb/cbb Adapted Two-Round Alternating Experiment 
Due to the unexpected result shown in the Balb/cbb adapted experiment, where 
fitness and virulence was reduced in all treatments in the test phase, we conducted 
another sub-experiment with a FVC strain adapted to the Balb/cbb genotype. These 
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additional experiments were done in order to test if the expected pattern where passages 
through alternating MHC genotypes reduces titer and virulence, holds true when the virus 
is adapted to the Balb/cbb genotype to overcome some of the inherent host resistance. We 
used a previously generated virus that was adapted to the Balb/cbb host genotype through 
ten rounds of passage in order to obtain an adapted virus to the resistant genotype 
(Kubinak et al., 2012b). The previously described Balb/cbb experiment was repeated with 
the new Balb/cbb stock adapted through ten rounds of passage. Again, three different 
passage treatments were conducted, in which the virus was passaged through either pure 
passage lines (Balb/cbb in each round) or alternating passage lines (different MHC 
genotype in the second round of passage, Balb/ckk or Balb/cdd). Again, a test phase was 
conducted in the original host strain of passage with the same dilution scheme, in order to 
test for differences between passage treatments. 
 
2.3.6 Statistics 
All statistical analyses were completed in R (3.3.1) (R Core Team, 2016).Titer 
data was multiplied by spleen mass in order to obtain total viral titer per spleen estimates 
and spleen mass and titer data was log10 transformed due to its non-normal nature. Data 
pooled between the initial stock two round experiments were analyzed using linear mixed 
model in the lme4 package with response variables of either viral titer or spleen mass and 
a fixed effect of treatment (Bates et al., 2014). A random effect of host genotype was 
included in order to control for variation due to different resistance patterns in the host 
strains between experiments, p-values were obtained using the R package lmerTest (2.0-
33) (Table 2S.1) (Kuznetsova et al., 2016). Furthermore, each individual stock two round 
23 
 
experiment was analyzed by a one-way ANOVA with corresponding Tukey post-hoc 
tests to determine differences between each treatment group. The Balb/cbb adapted 
experiment was analyzed separately from the two round alternating experiments and was 
also analyzed by a one-way ANOVA with post-hoc Tukey tests to determine differences 
between passage lines. All data in figures represent mean ± SEM. All data will be 
uploaded to an online repository, such as DRYAD, upon acceptance. 
 
2.4 Results 
2.4.1 Stock Two-Round MHC Alternating Passages 
Overall, MHC experiments show a significant reduction in viral fitness and 
virulence when the virus went through an alternated passage regime versus a pure 
passage regime. FVC stocks derived from alternated passage demonstrated a 41% 
reduction in titers compared to pure passaged FVC (LMM; t = -3.72, p < 0.001) (Figure 
2.2A). SFFV titer showed a similar overall pattern where alternating passages have lower 
titers than pure passage lines (LMM; t = -3.53, p = 0.001) (Figure 2S.2). Furthermore, 
virulence of FVC was reduced by 55% in alternating passages when compared to pure 
passage lines (LMM; t = -3.42, p < 0.001) (Figure 2.2B).  
Viral titer measures demonstrated a statistically significant overall reduction in 
fitness in alternated passages when the three two-round stock experiments are pooled, 
however, not all comparisons for viral titer in each individual experiment were 
significantly reduced (Figure 2.3A-C). The Balb/cdd experiment showed a significant 
difference in viral titer between the experimental groups (Figure 2.3A) (ANOVA; F(2, 31) 
= 4.9, p = 0.01). Specifically, there was a significant reduction of FVC titer when 
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passaged through both alternated Balb/cbb (Tukey, p  = 0.02), and alternated Balb/ckk 
lines (Tukey, p = 0.05) relative to pure passage lines. Similarly, when FVC was passaged 
in the Balb/ckk experiment there were significant differences between viral titer of 
experimental groups (Figure 2.3B) (ANOVA; F(2, 21) = 11.4, p < 0.001). In this case, a 
significant reduction in viral titer was observed only when FVC was passaged through 
the Balb/cbb genotype when compared to pure passage lines (Tukey, Balb/cbb, p < 0.001; 
Balb/cdd, p = 0.12). The Balb/cbb experiment did not show the predicted effect and there 
was actually an increased viral titer when FVC was passaged through the alternating 
Balb/cdd genotype (Figure 2.3C) (Fitness, ANOVA, F(2, 24) = 10.4, p < 0.001; Tukey, 
Balb/cdd, p = 0.02, Balb/ckk, p = 0.27).  
Spleen mass showed similar results to the titer data; the overall data showed 
alternating passages had a statistically significant virulence reduction compared to pure 
passages, however, the trend was not consistent among sub-experiments. The Balb/cdd 
sub-experiment showed a statistically significant relationship between groups (Figure 
2.3D) (ANOVA; F(2, 39) = 4.9, p = 0.013), though, there was only a statistically significant 
reduction in virulence when FVC was passaged through the alternated Balb/cbb lines 
(Tukey, p = 0.009) and only slightly reduced in the alternated Balb/ckk lines (Tukey, p = 
0.225). The Balb/ckk sub-experiment also showed a statistically significant relationship 
between groups (ANOVA; F(2, 25) = 8.1, p = 0.002) with each of the alternated lines 
showing reduced virulence, but only the Balb/cbb lines showing statistically significant 
reductions (Figure 2.3E) (Balb/cbb Tukey, p = 0.001; Balb/cdd Tukey, p = 0.270). Again, 
the Balb/cbb stock experiment did not show a reduction in virulence in alternating 
passages and there was an increase when the virus went through an alternating Balb/cdd 
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passage (Figure 2.3F) (ANOVA, F(2,27) = 10.9, p < 0.001; Tukey; Balb/cdd, p < 0.001). 
 
2.4.2 Two-Round Balb/cbb Adapted Experiment 
In the experiment using a Balb/cbb adapted virus, a reduction in both titer and 
virulence was observed when FVC was passaged through animals with alternated MHC 
genotypes, though again not statistically significant in each alternating passage (Fitness, 
ANOVA; F(2, 23) = 20.3, p < 0.0001; Virulence, ANOVA; F(2, 27) = 19.7, p < 0.0001; 
Figure 2.4). Individually, there was only a significant reduction in titer and virulence 
when passaged through the Balb/ckk haplotype (Titer, Tukey p < 0.0001; Virulence, 
Tukey, p < 0.0001) (Figure 2.4A-B).  Passaging FVC through the Balb/cdd genotype did 
show a reduction in the means in both titer and virulence from pure passage, however, 
this reduction was not significant (Tukey; titer, p = 0.93; virulence, p = 0.97). 
 
2.5 Discussion 
The data presented here support the hypothesis that increased MHC diversity in 
host populations impedes pathogen adaptation as evidenced by reduced fitness and 
virulence. Though we do not see significant reduction of viral titer and virulence in each 
individual alternating passage, in general, there is an overall 41% reduction of viral titer 
and 55% reduction in virulence when FVC is passaged through alternated hosts compared 
to pure-passage hosts when variation between experiments is controlled in a LMM. The 
reductions in virulence observed here provide a mechanism for how pathogens, forced to 
adapt to multiple MHC genotypes encountered in natural populations, are not able to 
attain the virulence that has been observed in serial passages through isogenic hosts.  
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The initial two round stock Balb/cbb experiment did not show the predicted 
pattern; one explaination may be that due to the high resistance of the Balb/cbb, the 
resistance overshadows the effects that are expecting in alternating passages (Kubinak & 
Potts, 2013). If true, then a virus more adapted Balb/cbb might allow the predicted pattern 
to emerge. In order to test this hypothesis, we repeated the Balb/cbb experiment with a 
Balb/cbb adapted virus serially passaged through ten rounds. When FVC was able to adapt 
to the Balb/cbb genotype, our hypothesized pattern emerges: there is a reduction of fitness 
and virulence in the alternated lines when compared to the pure passage lines, though 
only significant in the Balb/ckk alternated lines. Interestingly, the virus alternated through 
Balb/cdd had significantly higher virulence and titer in the test phase than pure passage 
suggesting the susceptibility of MHC genotypes is an important interacting variable. 
These experimental data are consistent with other correlative studies showing a reduction 
in pathogen load when many different MHC alleles are present in a population (Meyer-
Lucht & Sommer, 2005; Sin et al., 2014). Furthermore, by allowing the virus to adapt to 
the most resistant MHC genotype, making these hosts more susceptible, we 
experimentally support the negative frequency-dependent predictions of the RQ 
hypothesis, demonstrating the dynamic character of such coevolutionary interactions 
(Borghans et al., 2004; De Boer et al., 2004). Though the results presented here do not 
completely rule out other hypotheses that may be maintaining MHC diversity in 
populations, it does show that negative frequency-dependent selection is one force 
maintaining diversity and that more work needs to be completed. 
MHC diversity is thought to be maintained in vertebrate populations through three 
nonmutually exclusive mechanisms: non-random mate preference, heterozygote 
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advantage and negative frequency-dependent selection (Kubinak et al., 2012a; 
Brockhurst et al., 2014).  Here we provide evidence for negative-frequency dependent 
selection in two ways. First, as MHC genotypes are alternated during serial passage of the 
virus, they supply a different selective pressure than the pure passage causing the virus to 
experience a fitness cost when each new MHC genotype is adapted to by the virus. These 
tradeoffs are essential for establishing molecular arms races and give rise to the attendant 
negative frequency-dependent selection. Second, the initial experiment through the 
resistant Balb/cbb genotype did not show reduced titer or virulence during alternated 
passages (compared to pure passages). However, FVC is capable of adapting to the most 
resistant MHC genotype (Balb/cbb) when passage through ten rounds, thereby making the 
host more susceptible and allowing the expected patterns of reduced virulence during 
alternated passages to emerge in subsequent experiments (Kubinak et al., 2013). The 
adapted Balb/cbb experiment models what might be expected in populations where the 
rare MHC alleles are initially not the targets of pathogen adaptation, but over time they 
become more common and consequently less resistant because they are now more 
frequent targets of pathogen adaptation. However, this dynamic is not seen in the initial 
experiment because hosts genotypes in their high resistance (rare) phase can dominate 
and overwhelm typical MHC-specific virulence patterns.  
These data demonstrate that population-level MHC diversity is beneficial to hosts 
because it reduces virulence evolution. It follows that a selective advantage will arise in 
families where both parents are MHC dissimilar because virulence is reduced as it moves 
through the different MHC genotypes of a family; providing a familial level function for 




In many serial passage studies from Daphnia to mice, virulence has been shown 
to increase by orders of magnitude (Ebert & Bull, 2003; Kawecki et al., 2012; Kubinak et 
al., 2012b, 2013); however, the underlying mechanism of this adaptation is unknown. We 
provide evidence that the increases in virulence of FVC are due at least in part, to 
specialization of the pathogen through specific MHC genotype adaptation; as MHC plays 
a major role in the interactions pathogens have with hosts and as the pathogen increases 
in virulence by adapting to one specific MHC genotype it incurs trades-offs in other 
MHC genotypes (Kubinak et al., 2012b). The 36% reduction in virulence observed when 
the pathogen is passaged through two hosts with dissimilar MHC genotypes supports the 
hypothesis that diversity at MHC loci is a controlling factor for virulence evolution. 
Increasing the amount of MHC diversity in host populations provides an advantage for 
each individual in that population as it reduces the probability a pathogen that infects 
them will have seen a similar MHC genotype during the previous infection. 
Serial passage is a useful tool in coevolution studies and many have shown an 
increase in fitness and virulence of various pathogens using these techniques (Ebert, 
1998; De Bruin et al., 2008; Mackinnon et al., 2008; Wei et al., 2014). Many of these 
studies have focused on pathogen interactions with species changes or sexual vs. asexual 
passages (Coffey & Vignuzzi, 2011; Ciota et al., 2015), but not passages of pathogens 
through different genotypes of the same vertebrate host species, as was done here. 
Furthermore, only a few of these serial passage studies have incorporated MHC allelic 
diversity into their passage schemes; which is thought to cause pathogen fitness tradeoffs 
through antagonistic relationships when the number of MHC alleles are increased in 
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populations (Radwan et al., 2010). Only Kubinak et. al. provided experimental evidence 
that between host genetic diversity reduces pathogen fitness and virulence in a vertebrate 
Mus host, however this work was done with hosts that differed throughout the genome, 
not just at the MHC region (Kubinak et al., 2015). Confirming strong effects of MHC 
diversity alone during experimental evolution highlights the importance MHC-specific 
adaptations have on viral evolution and represents the first experimental demonstration of 
diversity at specific loci impeding pathogen virulence evolution. 
Though this study shows a strong relationship between MHC diversity and 
pathogen evolution, we do not take into account natural transmission or other pathogens. 
Removal of the cost of transmission could lead to increased virulence of the pathogen 
(Ebert & Bull, 2003; Alizon et al., 2009), however, evidence suggests this is not causing 
the effect in our system. As host genotypes are alternated we see the associated costs in 
the new hosts with the same transmission route suggesting that viral interactions with the 
host MHC genotype is driving the adaptations and tradeoffs independent of removing the 
cost of transmission (Figure 2.2). Unfortunately, the relative importance of transmission 
and host genetics in virulence evolution is not known and needs to be investigated 
further.  Moreover, FVC is a lab strain of virus and may not be found in this form in 
natural systems; however, other viruses such as Dengue virus have replication 
incompetent particles that enhance virulence much like SFFV, so this system may enable 
better understanding of the role of these defectives (Ke et al., 2013). Furthermore, due to 
its similar life cycle, FVC is a good model to use to understand other ecologically 
relevant retroviruses, such as HIV, Simian immunodeficiency virus, Bovine leukemia 
virus, and Koala retrovirus (Pollari et al., 1992; Tarlinton et al., 2006; Myers & 
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Hasenkrug, 2009; Hartmann, 2012). Furthermore, we would like to point out that though 
we used congenic inbred animals we do not know if each strain is the same across the 
genome outside of the MHC region. However, if this is the case we would expect the 
effects to be small compared to the effects of the MHC region as there has been much 
less time for large changes to occur that influence pathogen defense in the rest of the 
genome due to the pathogen free nature of these animals. Future work should focus on 
the relationships between naturally transmitting pathogens and population wide MHC 
diversity in order to understand the relative importance each plays in their coevolutionary 
system.   
Here we demonstrate that RQ dynamics contribute to virulence evolution by 
showing trade-offs in FVC fitness and virulence when it encounters a host with a novel 
MHC genotype, though many different factors may contribute to these trade-offs as well. 
These data suggest that the high virulence seen in serial passage studies may not be seen 
in nature due to the continual selection placed on the virus with each transmission event 
into a host with a novel MHC genotype. Furthermore, as the virus adapts to the most 
resistant genotype, we observed MHC trade-offs emerge when new (alternating) 
genotypes are encountered, as would be expected through negative-frequency dependent 
selection. These data shed light on the importance host pathogen co-evolutionary 
relationships play in the maintenance of MHC diversity and how this diversity is 
important for virulence evolution; having practical implications for endangered and 
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acquires enhanced pathogenicity and transmissibility after serial passages in Swine. 








Figure 2.1. Serial passage of FVC through MHC congenic mice. Virus was 
administered intraperitoneally. After 12 days of incubation it was split three ways and 
was passaged into a host of the similar MHC genotype (round 2 pure) as well as two 
different MHC genotypes (round 2 alternating). During the test phase, each round two 
virus was passaged into the original host of passage (round 1 genotype) in order to 
control for host differences in the test phase. Furthermore, each round was completed 
with ten replicates in each MHC genotype treatment group, denoted by x10. Each panel 












Figure 2.2. Virulence and titer of FVC in the test phase among all experimental 
treatments. (a) The titer of FVC was significantly reduced when passaged through 
alternating MHC host genotypes. (b) There was also a significant reduction of virulence 
(Spleen mass) when FVC was passaged through an alternating host. Symbols represent 
the experiment the data point came from: Balb/ckk (triangle), Balb/cdd (circle) and 






Figure 2.3. Alternating MHC genotypes reduces both titer and virulence of FV 
complex. (a-c) There was a significant reduction of viral titer in three out of six 
alternating passages across each sub-experiment; furthermore, titer was reduced below 
pure passages in each alternating passage, though not significantly, except the Balb/cbb 
sub-experiment. (d-f) Virulence of FVC showed a significant reduction in two out of six 
possible alternating passages, again, virulence was reduced from pure passages in all 
cases though this reduction was not always significant. The Balb/cbb experiment did not 
show the expected result with regard to either titer or virulence. Data represented by 





Figure 2.4. Viral titer and virulence using the Balb/cbb adapted virus. (a) Alternating 
the MHC genotype shows a significant reduction in titer between groups, however, much 
of this significant effect is driven by the virus that is alternated through Balb/ckk 
genotypes with a minor reduction in titer when passaged through Balb/cdd .  (b) Likewise, 
there was significant reductions between groups in virulence of FVC. Again, the 
reduction in virulence was only significant when alternated through Balb/ckk MHC 
haplotypes, with only a slight reduction in Balb/cdd passages. Data represented by mean ± 









Figure 2S.1. Correlation between SFFV and F-MuLV titers. Only qPCR data from F-
MuLV genomes was collected and reported due to the significant correlation between the 
two viral genomes that make up FVC: Friend Murine Leukemia Virus (F-MuLV) and 











Figure 2S.2. Virulence and titer of SFFV in the test phase among all experimental 
treatments. (a) The titer of FVC was significantly reduced when passaged through 
alternating MHC host genotypes. Data represented by mean ± SE. ** Indicates a P value 








Table 2S.1. Linear mixed models comparing treatment groups (pure and 
alternated), controlling for host genotype. 
Virulence (Spleen mass) of test phase animals by treatment 
LMM (groups: Host = 3; observations 100) 
Random effects Variance  Std. Deviation  
Host 0.1059 0.3254 
Fixed effects  Estimate Std. Error t value Pr(>|t|) 
Intercept (Pure Passage) -0.1607 0.2078 -0.773 0.50458 
Treatment (Alternated  Passage) -0.3708 0.1086 -3.415 0.00094 *** 
F-MuLV titers (log transformed) of test phase animals by treatment 
LMM (groups: Host = 3; observations 85) 
Random effects Variance  Std. 
Deviation 
 
Host 1.4087 1.1869 
Fixed effects  Estimate Std. Error t value Pr(>|t|) 
Intercept (Pure Passage)  4.1895 0.7278  5.756 0.01952 * 
Treatment (Alternated  Passage) -1.1970 0.3214 -3.724 0.00036 *** 









NATURAL HORIZONTAL TRANSMISSION OF A MURINE 
RETROVIRUS WITHIN SEMINATURAL  
POPULATIONS OF MICE 
 
3.1 Abstract 
Transmission is a key component of a pathogen’s life history and more robust 
systems need to be developed to obtain reliable ecological estimates of the dominant 
mode(s) of transmission and determine how host traits such as sex and social status 
influence transmission dynamics. We have developed such a system, using seminatural 
populations of house mice and use it to evaluate the transmission dynamics of Friend 
Virus Complex (FVC). Seven seminatural populations were founded with 8 male and 16 
female mice that were either “index” (initially infected) or “contact” (initially 
uninfected). Three experimental population designs were implemented: female index 
only, male index only, and female and male index. We found that male-male transmission 
is the predominant mode of transmission with little female transmission and no evidence 
of vertical transmission. Additionally, infected contact males harbor higher titers than 
females while suffering a similar amount of virulence; this paired with a strong 
correlation between titer and virulence in males and no correlation in females suggests 
FVC may be male adapted. We also found that contact animals had lower titers than 
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index animals at the end of the experiment suggesting FVC replication is reduced. 
Finally, social status influences infection, as though dominant and nondominant males 
contract the virus at similar rates and experience similar virulence, nondominant animals 
have higher titers. These results shed light on the complex life cycle of murine leukemia 
viruses and their evolutionary history and may also help develop a better understanding 
of the role of host sex, and social status on retroviral transmission dynamics. 
 
3.2 Introduction 
Pathogen life history is complex and consists of many barriers that when passed 
coalesce in infection, and one of these consequential life history challenges is 
transmission (Mccallum et al., 2017). Therefore, understanding the mode(s) of 
transmission and how this mode influences pathogen virulence is a large and ongoing 
area of research (Antonovics et al., 2017). Historically it has been difficult to obtain 
reliable estimates of transmission, due to the biased nature of collection methods (i.e., 
only symptomatic individuals measured), and of the many factors controlling successful 
transmission of pathogens (Antonovics, 2017; Walker et al., 2017). Specifics about 
pathogen transmission dynamics such as, the transmission efficiencies of various modes 
and the  influence of host sex, social status, and age are difficult to obtain in natural 
settings due to all the competing factors involved in transmission; addressing these 
shortcomings requires design of better experimental systems to obtain reliable estimates 
of the movements of different pathogens under a host of ecological conditions (Arthur et 
al., 2017). 
Transmission mode, how a pathogen moves between hosts, influences both the 
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likelihood of successful infection and resulting virulence experienced by the host. 
Pathogens are often opportunistic and use many different modes to infect subsequent 
hosts; however, some of these modes may allow for more likely transmission and higher 
pathogen burden than others (Antonovics et al., 2017). Experimenter transmission, 
wherein researchers directly infect a host with a pathogen, does not always mimic natural 
transmission modes (e.g., intraperitoneal injection with Friend Virus Complex (Portis et 
al., 1987; Ebert, 2013)). Also, it is thought that experimenter transmission removes the 
cost of transmission, potentially artificially increasing virulence (Ewald, 1983). 
Therefore, understanding the modes of transmission that a specific pathogen employs, 
their relative importance, as well as shifting away from experimenter to natural 
transmission is necessary to characterize the transmission ecology of host-pathogen 
systems.  
Through differences in physiology, hormone production, and immunity, host sex 
may be a powerful force driving differences in the transmission of pathogens (Zuk & 
McKean, 1996; Duneau & Ebert, 2012; Robinson & Klein, 2012). Males, for example, 
produce testosterone, which has been suggested to suppress the immune system, thereby 
increasing susceptibility to parasites and pathogens (Zuk, 1996). Many studies have 
examined the virulence in females in regards to vertically transmitted parasites (e.g., FVC 
in mice or Hepatitis C virus in humans) (Mirand et al., 1966; Thaler et al., 1991); 
however, few have explored differences in host virulence due to horizontal transmission 
or if transmission rates differ between the sexes. Furthermore, when sex biased horizontal 
transmission has been tested it has been measured indirectly using measures that correlate 
with transmission such as pathogen shedding or within host growth rates not successful 
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inoculation of another host (Perkins et al., 2008; Luong et al., 2009). The differences 
between the sexes in immunity, behavior, and other physiological processes may lead to 
key differences in transmission dynamics for a given parasite; unfortunately, the 
influence of host sex and potential sex-specific processes have not had rigorous 
characterization for most parasites (Klein, 2000). 
 Another important characteristic that can shape transmission dynamics is an 
individual host’s social status. Individuals of a species vary in physical condition, social 
connectivity, dispersal ecology, or possess heterogeneity in other traits that may bear 
importantly on their likelihood of contracting or transmitting a parasite (Arthur et al., 
2017; Stephenson et al., 2017); these heterogeneities and their influence on transmission 
dynamics may be associated with belonging to a specific social class, such as dominant 
or nondominant  (Hausfater & Watson, 1976; Hawley et al., 2007). Although specific 
relationships between social status and parasite transmission/virulence have been 
documented, general patterns across host and parasite species remain obscure (Arthur et 
al., 2017). Therefore, in order to understand the transmission ecology of a given 
pathogen, studies specifically assessing the influence of host social status are required. 
 Friend Virus Complex (FVC) is a murine specific retrovirus that has been widely 
used in laboratories to understand various aspects of the retroviral life cycle and 
immunity (reviewed in Hasenkrug & Chesebro, 1997; Myers & Hasenkrug, 2009). FVC 
has been shown to be transmitted both vertically (through milk) and horizontally 
(sexually from males to females), at least, within susceptible strains of laboratory mice in 
artificial caged environments (Mirand et al., 1966; Portis et al., 1987). Additionally, a 
related wild murine ecotropic virus has been shown to transmit between males in cage 
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trials, though, neither of these studies have focused on disentangling the various modes of 
natural transmission, even in caged environments, to determine their relative importance 
(Portis et al., 1987). Moreover, simply demonstrating that transmission can occur via a 
specific mode does not provide information about which mode of transmission is the 
most common in nature, or the route to which a pathogen is primarily adapted.  
 The commensal nature of house mice (Mus musculus) provides a unique 
opportunity to manipulate aspects of transmission ecology (e.g., density, sex-ratio of 
infected individuals) to determine how their pathogens move through a population in a 
controlled experimental setting. Experimental infections in house mouse populations 
inhabiting seminatural enclosures, when paired with appropriate titering, allow for 
quantifying contraction and transmission rates of pathogens and resulting virulence 
measures in an ecologically-relevant setting. The use of such enclosures has been 
advocated by the evolutionary and functional genomics community (Carroll & Potts, 
2006, 2007); however, until now their novel attributes have yet to be harnessed for 
disease ecology and epidemiology. 
Here we use wild-derived house mouse populations living under seminatural 
conditions to evaluate the virulence and transmission dynamics of a murine retrovirus 
(FVC). Specifically, we assess: whether horizontal or vertical is the dominant mode of 
transmission; which sex, if either, drives horizontal transmission; if there is a 
corresponding sex-specific virulence and pathogen titer pattern accompanying differences 
in transmission; if virulence and titer measures resulting from experimenter and natural 
transmission differ; and if male social status influences the observed virulence, titer, or 
transmission patterns. Regarding the dominance of horizontal vs. vertical transmission, 
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specific a priori predictions are difficult to formulate due to conflicting cage studies 
(Mirand et al., 1966; Portis et al., 1987). However, if sexual transmission is the main 
route of horizontal transmission then female mice should contract the virus at a higher 
rate than males (while males transmit at higher rates than females (e.g., Padian et al., 
1991; Looker et al., 2008), but if aggressive interactions are the main transmission 
mechanism, then males should have higher rates of both contraction and transmission as 
they more readily engage in fighting (Singleton & Krebs, 2007). Correspondingly, we 
predict that if one sex is primarily responsible for transmission then it will experience 
lower virulence due to infection than the other, according to theory (Anderson & May, 
1982). Also, if natural transmission involves more barriers to transmission, such as less 
opportunity, dose or different routes, than experimenter transmission, we predict that 
animals naturally contracting the virus will have lower titers and virulence than animals 
infected intraperitoneally (Ewald, 1983). Finally, if dominant males are in better 
condition than nondominant males they will have lower titers and virulence; however, if 
they expend resources defending territories and this results in a tradeoff with immune 
function they will develop more severe infection (Arthur et al., 2017). 
 
3.3 Methods and Materials 
3.3.1 General Methods 
3.3.1.1 Animals 
To assess transmission dynamics, mice with functional, wild type, behaviors are 
needed and it has been documented that standard laboratory strains have lost many of 
these behaviors (Nelson et al., 2013a; Chalfin et al., 2014).  Therefore, we employed 
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wild-derived genetically outbred house mice (Mus musculus) from the 14th and 16th 
generation of a colony initially described in reference (Meagher et al., 2000). For cage-
based experiments and before release into seminatural enclosures, individuals were 
provided access to food and water ad libitum and maintained on a 12:12 h light:dark 




FVC is an NB-Tropic gamma retrovirus that primarily infects erythroblasts 
causing gross splenomegaly in its murine host. FVC is composed of two separate 
genomes that work synergistically to cause disease. First, Friend murine Leukemia Virus 
(F-MuLV) is a prototypic gamma retrovirus which has all the proper machinery to infect 
and exit erythroblasts (for review see (Hasenkrug & Chesebro, 1997)). The second 
genome, Spleen Focus Forming Virus (SFFV), is capable of inserting into the genome, 
but cannot exit a cell without being pseudo-typed (packaged) in an F-MuLV capsid. 
However, SFFV’s truncated envelope gene can stimulate the Erythropoietin receptor 
(EpoR) causing uncontrolled proliferation of erythroblasts allowing for more target cells 
for F-MuLV and increasing the probability of the SFFV genome being pseudo-typed and 
exiting the host cell (Ruscetti, 1999; Kosmider & Moreau-Gachelin, 2006).  
Due to the erythropoietic nature of FVC the main sight of replication is the spleen 
(Metcalf et al., 1959). The dramatic increase in the size of the spleen allows for an 
estimate of the amount of harm (i.e., virulence) the host is experiencing during infection. 
After sacrifice, the spleen is harvested and the mass measured. 
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F-MuLV viral titers were measured by qPCR amplification of retroviral 
integrations from the host genome (provirus) using primer sets and protocols described 
previously (Kubinak et al., 2012). Provirus quantification, as opposed to Ribonucleic 
Acid (RNA) measurements, was used because it is a measure of productive viral genomes 
that have inserted into the genome. Quantitative PCR was used to obtain estimates of 
viral fitness from spleen homogenates using the Lightcycler 2.0 platform. Crossing points 
above cycle 36 were requantified and if still over that threshold the sample was treated as 
uninfected per the manufacturer’s recommendation due to the unreliability of quantifiable 
estimates at that number of cycles. Each proviral estimate was normalized to a 
Glyceraldehyde Phosphate Dehydrogenase (GAPD) reference to obtain relative per cell 
genome estimates. Furthermore, each proviral GAPD ratio was multiplied by spleen mass 
in order to get proviral load per spleen estimates; this estimate was used in all analysis 
except the correlations of F-MuLV proviral load by spleen mass, due to its potential to 
inflate the significance of the correlation.   
Only SFFV infection status (positive/negative) was measured due to the high 
level of endogenous DNA and expressed RNA similar to SFFV found in wild-derived 
mice. SFFV was amplified from RNA with the following primer sets, Fwd – 
5’GTTCGCGCGCTTCTGCTTCC3’, Rev – 5’ACAGCGAGACCACGAGTCGG3’, 
using the Verso RT-PCR kit by Thermo Scientific on a Biorad c1000 touch machine used 
per manufacturer recommendations. PCR products were run on a 1% agarose gel in order 
to determine the presence or absence of the ~170 bp fragment of SFFV (Figure 3S.1). 
RNA extractions were completed using the Zymo Quick-RNA MiniPrep kit in order to 
obtain pure RNA template for PCR.  
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A Bioclone FVC stock was cultured from a transfected a NIH3T3 cell line, 
culture supernatants were collected, aliquoted and frozen at -70°C until needed. The 
resulting Bioclone stock was not virulent enough to cause disease in wild-derived mice; 
therefore, a Mus-adapted stock (as opposed to cell-culture adapted) capable of infecting 
animals in the study was generated. To create this stock, Bioclone was serially passaged 
through two rounds of BALB/c female mice. After two rounds of passage, each of the 14 
animal’s spleens were homogenized and pooled. Supernatants were collected from the 
pooled spleens and stored at -70°C until needed. The resulting virulent FVC stock did 
produce larger spleens in wild-derived mice than Bioclone (virulent stock: 0.27 ± 0.07 g, 
Bioclone: 0.05 ± 0.008 g; WRS; n = 48, W = 168.5, p = 0.019).  Furthermore, within 
cages female mice experienced higher virulence from FVC infections with our virulent 
FVC stock than did males, but only a marginal increase of F-MuLV titers was observed 
in females over males. Twelve days postinfection females had spleens averaging 0.45 ± 
0.13 g (M ± SEM), which were 3.46 times the mass of male spleens which were 0.11 ± 
0.04 g (WSR; n = 28, W = 158.5, p = 0.005; Figure 3S.2A). However, only a marginally 
statistically significant difference in F-MuLV titers per spleen (F:M; 2.07 ± 0.33: 1.17 ± 
0.32) was observed between the sexes (t-test; t = 1.97, p = 0.060 [Figure 3S.2B]). 
Interestingly, a correlation between spleen mass and titer was not identifiable in this data 
set (LM; t = -0.55, p = 0.209; Table 3S.1). 
 
3.3.1.3 Seminatural Enclosures 
Enclosures are 30 m2 and subdivided into six subsections by wire mesh to 
promote territorial formation (Figure 3.1). Subsections contain ad libitum food and water 
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dispensers associated with a set of nest boxes in one of the four “optimal” territories, 
enclosed dark nesting sites, or two “suboptimal” territories, with nest boxes exposed to 
the light. Descriptions of enclosure, including additional photographs, and 
establishment/maintenance methods have been provided elsewhere in more detail (Ruff et 
al., 2013, 2015a; b, Gaukler et al., 2014, 2016). Populations are founded by 24 mice (16 
females; 10 males); densities and sex ratio were selected to be similar to those reported in 
the wild (Singleton & Krebs, 2007). Populations in this study were maintained for 7 
weeks, at which point founders and any offspring born within enclosures were sacrificed 
and organs were harvested to assess virulence measures and viral titers. 
Prior to release in seminatural enclosures both contact and index female founders 
were genotyped and categorized by a common mitochondrial allelic variant. Offspring 
collected at the termination of the populations were then typed so that the treatment of 
their mother could be determined. Mitochondrial types from all 108 offspring were 
gathered from populations containing female index animals and offspring were classified 
as having come from either contact (83) or index females (25). Information on primer 
design and PCR and gel electrophorese protocols have been described previously 
(Meagher et al., 2000).  
Prior to release into enclosures, founders of both sexes were implanted with 
unique passive integrated transponder (PIT) tags (TX1400ST, BioMark, Boise ID). 
Location data were gathered via a set of PIT antennae and readers (FS2001F-ISO, 
BioMark, Boise ID) placed at each of the feeders and data are recorded with data-logging 
software (Minimon, Culver City, CA). Dominance was assigned when a male had more 
than 80% of all male readings at a single feeder over the majority of the study as in 
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previous studies (Morris et al., n.d.; Nelson et al., 2013b). 
 
3.3.2 Study Design and Statistical Analyses 
3.3.2.1 Initial Evaluation of FVC Natural Transmission 
 
To determine if natural transmission of FVC is possible within seminatural 
enclosure populations a single pilot population of 24 mice (16 female and 8 male) was 
established with both female and male index mice (initially infected via IP injection) as 
well as contact mice (initially uninfected) of both sexes, resulting in half of the animals 
being contact and half being index. These mice were from the 14th-generation of the 
aforementioned colony and were 76.9 ± 12.1 (M ± SD) weeks of age.  
 
3.3.2.2 Relative Importance of Horizontal Versus  
Vertical Transmission 
Infection status was assessed in the offspring of index females as described above 
and the rate of infected offspring was compared to the observed rates of horizontal 
transmission in adults. As no offspring tested positive for F-MuLV titers a one-sample t-
test was used to compare rates of horizontal transmission across populations to the 
hypothetical value of 0. 
 
3.3.2.3 Influence of Host Sex on Horizontal  
Transmission Dynamics 
 Once natural transmission of FVC was confirmed six additional populations were 
established to determine the influence of host sex on FVC transmission dynamics. Two 
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populations were designed as described above with both female and male index founders, 
two populations had only female index founders, and the last two had only male index 
founders (Figure 3.1B). All populations contained 30 mice (20 female and 10 male) that 
were 13.6 ± 2.7 weeks old and study duration was again 7 weeks. To assess the effect of 
contact (female and male) and index host sex (female, male, and both sexes) on contact 
FVC infection status, we used a generalized linear mixed model (GLMM) to predict the 
probability of infection status; this and all other GLMMs were fit in R using the glmer 
function of the lme4 library (Bates et al., 2015; R Core Team, 2016). As infection status 
was defined as either infected or uninfected, we used a model assuming a binomial 
distribution with a logit link. Infection status was assessed in contact animals that 
survived the duration of the trial (n = 112) and these mice were grouped into seven 
populations, (the initial pilot population was included) from which individual 
observations for female and male contact mice were made (observations = 14). Contact 
and index sex were treated as fixed effects and population was modeled as a random 
effect. The model intercept was set for female contact animals from populations with 
only female index animals. 
 
3.3.2.4 Influence of Host Sex and Transmission on  
Virulence and Pathogen Fitness 
 Comparisons of spleen mass and viral titers were obtained between index and 
contact animals in order to determine the effect natural transmission has on FVC’s ability 
to replicate and cause disease. All surviving animals were assessed for infection status by 
spleen mass and viral titer then each measure was pooled in order to obtain overall 
55 
 
virulence and titer estimates; in total, 75 observations were assessed out of the seven 
populations. Comparisons between contact and index virulence and titer were performed 
using linear mixed models (LMM) from R packages lmer4 and degrees of freedom and 
resulting p-values were estimated using lmerTest (Kuznetsova et al., 2016). Furthermore, 
in order to determine the effect host sex has on titer and virulence models were 
performed on each viral measure of contact animals; host sex and infection status were 
used as fixed effects and population as a random effect, as was done previously. To 
ensure that population design (sex of index mice) did not influence virulence and viral 
titer, and impair the ability to compare virulence and F-MuLV titers of contact and index 
mice, we performed a LMM. No significant effect of population design was observed 
(Figure 3S.3, Table 3S.2). 
 
3.3.2.5 Influence of Male Social Status on Transmission,  
Virulence and Titer of Naturally Transmitted FVC 
To determine the effect social dominance has on transmission, virulence, and titer, 
comparisons were made using both GLMMs and LMMs. The influence of social 
dominance on transmission was determined by comparisons made between the 
transmission efficiency between surviving dominant and nondominant contact animals (n 
= 40). Due to the binomial nature of transmission data GLMMs were utilized again 
assuming a binomial distribution and a logit link. Social status was used as the fixed 
effect with population again used as a random effect. In order to determine the influence 
of social status on virulence and titer, LMMs were utilized due to the continuous nature 
of the data analyzed. Each LMM was conducted on 22 observations throughout the seven 
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populations and each model consisted of social status as the single fixed effect followed 
by population as the lone random effect. 
 
3.4 Results 
Overall rates of horizontal transmission to contact founders in seminatural 
populations, regardless of the sex of index and contact mice, were 47.6 ± 7.6% (M ± 
SEM) (n = 7). Contrastingly, no offspring (0/25) born to index females had detectable F-
MuLV titers showing that vertical transmission did not occur. The observed difference in 
rates between horizontal and vertical transmission were statistically significant (t-test; t = 
6.29, p = 0.001). 
Male mice within seminatural enclosures were the major drivers of viral 
transmission dynamics as they were both more likely to contract and transmit F-MuLV 
than females. Across all populations contact males had contraction rates of 61.2 ± 10.3% 
and were 1.63 times more likely to contract F-MuLV than contact females who were 
infected with F-MuLV at a rate of 37.5 ± 10.3%; this difference was statistically 
significant (GLMM; Z = -2.37, P = 0.018; Figure 3.2A; Table 3S.3). Similarly, 
populations founded with only index males had transmission frequencies of 50.0 ± 7.1% 
(n = 2) (across both sexes of contacts), which were 2.51 times higher than rates in 
populations containing only index females (19.9 ± 2.3%; n = 2); again, this difference 
was found to be statistically significant (GLMM; Z = -3.135, p = 0.002; Figure 3.2B). 
Further support for male-driven transmission was observed as populations containing 
both female and male index mice did not have higher rates of transmission (63.5 ± 4.5%; 
n = 2) than those containing only index males (GLMM; Z = 1.04, p = 0.299; Figure 
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3.2B), despite containing more index individuals in total. 
Furthermore, SFFV transmission was also male biased, though males were not 
significantly more likely to contract SFFV than females they are more likely to transmit 
SFFV. Across all populations contact males had marginally significantly higher rates of 
SFFV contraction (GLMM; Z = 1.79, p = 0.073; Figure 3.2C; Table 3S.2). Furthermore, 
there is 2.31 times more transmission in populations founded by only male index mice 
than those founded by only female index mice (GLMM; Z = 4.14, p < 0.0001; Figure 
3.2D). Interestingly, populations founded with both male and female index animals did 
not have significantly higher SFFV transmission rates than female index populations 
(GLMM; Z = 1.74, p = .082; Figure 3.2D, 3S.3). 
Contact males showed a significantly increased F-MuLV titer over contact 
females (LMM; t =2.61, p = 0.011; Figure 3.3B; Table 3S.4), though there was no 
difference between the sexes in index animals. A strong correlation exists between 
virulence and titer in contact males (LM; r2 = 0.398, F1,20 = 13.23, n = 22, Table 3S.5), 
however, there is no relationship seen between virulence and titer in contact females 
(LM; r2 = 0.048 , F1,27 = 1.326, n = 29; Figure 3.3C). Furthermore, both male and female 
index mice had 2.39 times larger spleen mass than contact mice (LMM; t = 3.02, p = 
0.004; Figure 3.3A; Table 3S.4). However, there is no significant difference in virulence 
between the sexes in either contact or index mice (LMM; t = 0.25, p = 0.807; Figure 
3.3A). F-MuLV titer was significantly higher in index males and females when compared 
to contact animals (LMM; t = 4.35, p < 0.0001; Figure 3.3B). 
No effect of male social status was seen in regards to susceptibility as both 
socially dominant and nondominant male contact mice contracted F-MuLV at similar 
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frequencies (GLMM; Z = -0.08, p = 0.938; Figure 3.4A; Table 3S.6). Similar patterns 
were seen for rates of SFFV contraction (GLMM; Z = -0.03, p = 0.973; Figure 3.4B). Of 
males that contracted F-MuLV, social status did not influence spleen mass (LMM; t = -
1.19, p = 0.250; Figure 3.4C; Table 3S.6); However, F-MuLV titers were higher in 
nondominant relative to dominant males (LMM; t = -2.59, p = 0.018: Figure 3.4D). 
 
3.5 Discussion 
Within seminatural enclosures we demonstrated that horizontal transmission (and 
not vertical) is the primary mode of transmission, characterized asymmetrical rates of 
contraction and transmission between the sexes, that natural transmission results in less 
virulent infection than direct injection, that males which contract F-MuLV have higher 
titers than do females despite experiencing similar levels of virulence, and that male 
social status influences infection severity. Across all contact mice, rates of horizontal 
transmission of F-MuLV were 47.6%, while no offspring born to index females within 
enclosures tested positive. Male contact mice were 1.63 times more likely to contract F-
MuLV than contact females. Though there was no difference in spleen mass between 
male and female contact animals there was a significant increase (~ 1 order of magnitude) 
in titer in males over females. Index mice had 6.92 times the spleen mass as did contact 
mice. Finally, it was observed that social status did not influence contraction rates of 
FVC, nor the resulting virulence, but nondominant males were found to harbor F-MuLV 
titers that were ~ 2 orders of magnitude higher than dominant males. 
FVC horizontal transmission through sex and vertical transmission has been 
explicitly tested using inbred mouse strains in cages (Mirand et al., 1966; Portis et al., 
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1987); however, these studies did not take into account all modes of transmission 
simultaneously to determine their relative importance. Horizontal transmission is 
dominant to vertical transmission in this FVC system, as no evidence of vertical 
transmission was observed, even though previous studies have shown vertical 
transmission to occur at ~16% (Mirand et al., 1966). Because of the high rates of male 
contraction and transmission male-male agonistic encounters emerge as the likely main 
mode of FVC transmission. If sexual transmission were the main mode, we would predict 
patterns of high rates of female contraction and high rates of male transmission, which 
were not observed.  
The observations that males primarily contract and transmit FVC within 
seminatural enclosures, while possessing higher titers, but similar levels of virulence to 
females, is indicative that FVC, and potentially other MuLVs, may have an evolutionary 
history transmitting through males. Sex-specific transmission and virulence is a key life 
history characteristic of many parasites and pathogens (Zuk & McKean, 1996). Host sex 
can be an important selective pressure on pathogens, which are more likely to be 
transmitted or contracted by one sex than the other due to sex-based differences in 
behavior and physiology (Duneau & Ebert, 2012; Robinson & Klein, 2012). Sex-specific 
pathogen adaptation has been documented in invertebrate host-pathogen systems (Høeg, 
1995; Werren et al., 2008; Rosenkranz et al., 2010), and in the vertebrate systems of 
Myxozoa in fish (Whipps & Kent, 2006), and the mite Spinturnix andegavinus in bats 
(Christe et al., 2007). Experimental demonstration of pathogen adaptation based on host 
sex is currently limited to invertebrates (e.g., Daphnia (Duneau et al., 2012)). 
Mammalian models, such as the FVC/Mus system, are needed to explore the generality of 
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these patterns in species with adaptive immunity. Mammalian models will also be better 
models for human disease, where recent evidence is indicating that sex-specific adaption 
may be an important phenomenon (Úbeda & Jansen, 2016). 
 The finding that male social status influences F-MuLV titers, but not spleen size 
or prevalence, highlights the complicated interactions between social status, individual 
immune function, and virulence (reviewed in Fairbanks & Hawley, 2012). Two main 
hypothetical frameworks exist to explain the relationship between social status and cost 
of infection in vertebrates: 1) that dominant individuals expend more resources acquiring 
a territory and matings, leaving them less capable of investing in immune defenses to 
ward off infections (Folstad & Karter, 1992); and 2) that dominant individuals are in 
better condition, and therefore more resistant to pathogens as subordinates undergo stress 
associated with poor habitat and constant antagonism by dominant individuals (Sapolsky, 
2004) (for recent review of both paradigms see Habig et al., 2015). Unfortunately, the 
unusual pattern between viral titers and spleen size (virulence) in this study can be 
viewed to support either paradigm. Specifically, dominant males may be getting sicker 
per unit virus as they have lower titers but similar sized spleens as nondominate males; 
conversely dominant males may be in better condition than subordinates, and thus able to 
better regulate their viral load.  
In regard to prevalence in social vertebrates, typically dominant individuals are 
more parasitized than subordinates due to more frequent social interactions (Habig et al., 
2015); however, in this study both classes of males contracted F-MuLV at similar 
frequencies possibility due to male-male interactions as the primary driver of 
transmission (i.e., dominant males have more interaction with females but they do not 
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readily transmit the virus). To further dissect the interplay between social status, immune 
parameters, and pathogen virulence seminatural systems, like this one, are needed to help 
merge laboratory measures of immune function with truly natural systems. 
 Although this study advances our understanding of how a model retrovirus 
transmits in a naturalistic setting, there are a few limitations in interpreting the results. 
First, variation exists in the infection duration of contact animals (i.e., some contact mice 
contract FVC earlier in the study than others) likely leading to inflated variation in titers 
and spleen mass of contact mice; this may cause us to miss patterns that would become 
apparent with more temporal control. Likewise, comparisons between contact and index 
mice are temporally disjointed in the sense that index mice are all infected prior to release 
into enclosures and contacts are infected throughout the study; additionally, index mice 
are likely infected with higher doses of virus via IP injection than contact mice. 
Moreover, vertical transmission may not have been seen in this study due to two reasons: 
first, wild-derived mice are much more resistant to FVC than the inbred mice used 
previously; second, vertical transmission was measured at 1-4 weeks postbirth in this 
study and anywhere from 5 to 8 months postbirth in previous studies (Mirand et al., 
1966). Finally, the inability to use qPCR-based techniques to quantify SFFV due to 
expression of endogenous retroviral RNA limits our ability to integrate SFFV fully into 
our understanding of FVC transmission dynamics. 
Understanding how MuLVs naturally move through populations is important for 
more than just Mus populations, as related retroviruses have been found across taxa of 
terrestrial vertebrates and are thought to be important for emerging infectious diseases 
(Martin et al., 1999). Furthermore, the transmission of leukemia viruses such as Feline 
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Leukemia Virus in the endangered Florida Panther (Puma concolor coryi) are of great 
interest to conservationists trying to restore natural populations of these animals not to 
mention the effects of these viruses on domestic felines (Cunningham et al., 2008; 
O’Brien et al., 2012). The power of seminatural enclosures allows for the elucidation of 
the factors contributing to the natural history of murine leukemia like viruses. 
Furthermore, characterizations of the transmission dynamics of various pathogens under 
natural or seminatural conditions, such as the one done here,  may provide insight into 
better combating emerging infectious disease, and established wildlife and human 
pathogens (Antonovics et al., 2017). 
Using seminatural enclosures and wild-derived mice we have characterized the 
transmission dynamics of a classic model retrovirus. In doing so, we have demonstrated 
that the prevailing understanding—that FVC is primarily vertically transmitted through 
mothers milk, or transmitted horizontally through sex (Mirand et al., 1966; Portis et al., 
1987)—is not supported and that male-male transmission during aggressive interactions 
is likely the predominant mode of transmission. Furthermore, we illustrate that within 
seminatural enclosures males harbor higher titers than females while suffering similar 
virulence; collectively, with the observation that there is a strong correlation between 
nonspleen corrected titer and virulence in males and none in females suggests that FVC is 
male adapted. Additionally, we demonstrated that male social status influences aspects of 
infection in an unexpected way: though dominant and nondominant males contract the 
virus at similar rates, and experience similar levels of virulence, dominant males have 
lower titers than do nondominant individuals. Understating the natural transmission 
dynamics of model pathogens will lead to better interpretations of the results of 
63 
 
laboratory experiments by framing them in an ecological and evolutionary context, while 
studies with seminatural host-pathogen systems promise to bridge the gap between 
laboratory and field studies and potentially shed light on the complex interactions of 
sociality and disease ecology. 
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Figure 3.1. Seminatural enclosure and population design. (A) Seminatural enclosure 
set up with six territories with four optimal territories (bins) and two suboptimal 
territories (small bins). (B) Study design showing three different population design 





Figure 3.2. Transmission dynamics of F-MuLV and SFFV in seminatural enclosures 
by contact (A-C) and index (B-D) mouse sex.  (A) Male contact mice (squares) 
contracted F-MuLV at rates 1.63 times higher than contact females (circles). (B) 
Populations founded with only index males (filled triangles) had transmission rates 2.51 
times higher across all contacts than those founded with only index females (open 
triangles), while rates did not differ in populations with only male index relative to those 
containing index animals of both sexes (diamonds). (C) No significant difference was 
seen between contraction in males and females in SFFV. However, male populations had 
2.31 times higher transmission than females. Interestingly, populations founded with both 
male and female index animals have reduced transmission efficiency than those founded 
by only index males and are only marginally significantly different from those founded 
solely by female index mice. Data points represent populations (n = 7), lines represent 






Figure 3.3. Spleen mass (A), F-MuLV titers (B), and their correlation (C) in female 
and male mice from seminatural enclosures. (A) Index mice (open symbols) of both 
sexes had spleens 6.92 times the mass of contact (closed symbols) animals, a log scale is 
used to enhance visualization.  (B) Males (squares) had higher F-MuLV titers, by ~ 1 
order of magnitude, than females (circles), but posthoc tests only confirmed this sexually 
dimorphic pattern between contact mice. Additionally, index mice of both sexes had titers 
~ 2 orders of magnitude higher than contacts. (C) Though spleen mass and F-MuLV 
titers were positively correlated in contact males, no such relationship was observed in 
females and the relationship between spleen mass and FMuLV titers significantly 
differed between the sexes. Data points represent individual mice, in A and B lines 
indicate means and error is standard error, while in panel C lines are regressions. from 
post-hoc Tukey multiple comparison tests. Dashed lines indicates that origin is below 





Figure 3.4. Influence of male social dominance on F-MuLV (A) and SFFV (B) 
contraction, virulence (C), and titer (D) in seminatural enclosures. (A) The 
dominance status of contact males did not influence their likelihood of contracting F-
MuLV; (B) this was also the case for SFFV. (C) Likewise, virulence as measured by 
spleen mass was not influenced by social status. (D) However, F-MuLV titers were 
higher in nondominant relative to dominant males Data points represent populations (n = 
7) in A, and individuals (n = 22) in B and C. lines represent means, and error bars 












Figure 3S.1. Gel showing the ~170bp SFFV fragment. Positive control (lane 2) shows 
the positive SFFV RNA fragment at ~170bp whereas the negative RNA controls (lanes 3-
4) do not. The ladder is represented in lane 1 and has the 500bp, 200bp and 100bp bands 









Figure 3S.2. Spleen mass (A) and F-MuLV titer (B) in female and male caged mice. 
(A) Females had spleens 3.46 times the mass of those of males twelve days post-
infection; a log scale was used to enhance visualization. (B) A trend was detected in 












Figure 3S.3. Influence of population design on virulence and titer(A) and F-MuLV 
titer (B). No significant influence of population design was seen on either spleen mass or 
F-MuLV titer of contact mice. For statistics see (Table 3S.5); no comparisons between 





Table 3S.1. Summary of LM results concerning viral titers and spleen mass of caged 
animals. 
F-MuLV	titers	(log	transformed)	by	spleen	mass	(log	transformed)	of	both	sexes	
Fixed	effects	 	 	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	(Female)	 	2.49	 0.43	 5.75	 <0.0001***	
Sex	(Male)	 -0.30	 0.88	 1.07	 		0.296	
Spleen	mass	(log	transformed)	 	0.94	 0.54	 -0.55	 		0.209	
Sex	(Male)	X	Spleen	mass	(log	transformed)	 	1.14	 0.80	 1.43	 		0.165	
SFFV	RNA	titers	(log	transformed)	by	spleen	mass	(log	transformed)	of	both	sexes	
Fixed	effects	 	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	(Female)	 -0.35	 0.40	 -0.88	 0.39	
Spleen	mass	(log	transformed)	 1.13	 0.46	 2.45	 0.02*	
Sex	(Male)		 -0.005	 0.73	 -0.006	 0.995	
Sex	(Male)	X	Spleen	mass	(log	transformed)	 0.19	 0.67	 0.29	 0.77	
SFFV	RNA	titers	(log	transformed)	by	F-MuLV	titers	(log	transformed)	of	both	sexes	
Fixed	effects	 	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	(Female)	 4.91	 2.10	 2.34	 0.03*	
SFFV	titer	(log	transformed)	 -0.37	 0.42	 -0.88	 0.39	
Sex	(male)		 -2.50	 2.34	 -1.07	 0.30	





Table 3S.2. Summary of LMMs concerning the virulence and titer of F-MuLV of 
contact mice by population design. 
Virulence	(Spleen	mass)	of	contact	mice	by	index	sex	
LMM	(groups:	7;	observations	=	51)	
Random	effects	 Variance		 Std.	Deviation	 	
Population	 0.020	 0.142	
Fixed	effects	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	 	0.717	 0.121	 	5.92	 0.001**	
Sex	(Female)	 -0.123	 0.103	 -1.19	 0.241	
Index	sex	(Female)	 -0.060	 0.199	 -0.30	 0.771	
Index	sex	(Male)	 	0.152	 0.164	 	0.93	 0.405	
F-MuLV	titers	(log	transformed)	of	contact	mice	by	index	sex	
LMM	(groups:	7;	observations	=	51)	
Random	effects	 Variance		 Std.	Deviation	 	
Population	 0.061	 0.247	
Fixed	effects	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	 -0.561	 0.360	 -1.56	 0.162	
Sex	(Female)	 -1.409	 0.387	 -3.65	 0.001	**	
Index	sex	(Female)	 	0.084	 0.602	 	0.14	 0.892	









Random	effects	 Variance		 Std.	Deviation	 	
Population	 	0.00	 0.00	
Fixed	effects	 Estimate	 Std.	Error	 Z	value	 Pr(>|z|)	
Intercept	(Contact	Female,	Index	Female)	 -2.12	 0.56	 -3.81	 <0.0001***	
Sex	of	contact	mouse	(Male)	 	1.16	 0.49	 	2.37	 	0.018*	
Sex	of	index	mice	(Male	only)	 	1.85	 0.59	 	3.14	 	0.002**	
Sex	of	index	mice	(Both	Female	and	Male)	 	2.35	 0.61	 	3.88	 <0.0001***	
SFFV	Transmission	by	contact	and	index	sex		
GLMM	with	binomial	distribution	and	logit	link	(groups:	populations	=	7;	observations	=	14)	
Random	effects	 	 Variance		 Std.	Deviation	 	
Population	 	 	0.00	 0.00	 	
Fixed	effects	 	 Estimate	 Std.	Error	 Z	value	 Pr(>|z|)	
Intercept	(Contact	Female,	Index	Female)	 	 -1.94	 0.55	 -3.54	 	0.0004***	
Sex	of	contact	mouse	(Male)	 	 		0.91	 0.50	 	1.79	 	0.0727	
Sex	of	index	mice	(Male	only)	 	 		2.55	 0.62	 	4.14	 	<0.0001***	
Sex	of	index	mice	(Both	Female	and	Male)	 	 		1.02	 0.59	 	1.74	 	0.0823	
F-MuLV	Transmission	to	contact	males	by	social	status	
GLMM	with	binomial	distribution	and	logit	link	(groups:	populations	=	7;	observations	=	14)	
Random	effects	 Variance		 Std.	Deviation	 	
Population	 	0.00	 0.00	
Fixed	effects	 Estimate	 Std.	Error	 Z	value	 Pr(>|z|)	
Intercept	(Nondominant	contact	males)		 	0.17	 0.41	 	0.41	 0.683	
Social	status	(Dominant)	 -0.05	 0.64	 -0.08	 0.938	
SFFV	Transmission	to	contact	males	by	social	status	
GLMM	with	binomial	distribution	and	logit	link	(groups:	populations	=	7;	observations	=	14)	
Random	effects	 Variance		 Std.	Deviation	 	 	
Population	 	0.00	 0.00	 	 	
Fixed	effects	 Estimate	 Std.	Error	 Z	value	 Pr(>|z|)	
Intercept	(Nondominant	contact	males)		 -0.20	 0.45	 -0.45	 0.655	





Table 3S.4. Summary of LMM results concerning titer and virulence 
measures between index and contact animals.  
Virulence	(Spleen	mass)	of	contact	and	index	mice	by	sex	
LMM	(groups:	populations	=	7;	observations	=	75)	
Random	effects	 Variance		 Std.	Deviation	 	
Population	 0.0137	 0.117	
Fixed	effects	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	 0.704	 0.098	 7.19	 <0.0001***	
Sex	(Male)	 0.032	 0.130	 0.25	 	0.807	
Type	(Index)	 0.489	 0.162	 3.02	 	0.004	**	
Interaction	(Male:Index)	 0.327	 0.238	 1.37	 	0.176	
FMuLV	titers	(log	transformed)	of	contact	and	index	mice	by	sex	
LMM	(groups:	populations	=	7;	observations	=	75)	
Random	effects	 Variance		 Std.	Deviation	 	
Population	 0.353	 0.594	
Fixed	effects	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	 -1.475	 0.364	 -4.06	 	0.001	**	
Sex	(Male)	 	1.095	 0.419	 	2.61	 	0.011	*	
Type	(Index)	 	2.310	 0.531	 	4.35	 <0.0001***	





Table 3S.5. Summary table of correlations of titer and virulence in contact animals 
FMuLV	titers	(log	transformed)	by	Virulence	(Spleen	mass)	of	contact	females	
LM;	r2	=	0.048	,	F1,27	=	1.326,	n	=	29	
Fixed	effects	 	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	 			1.077	 0.385	 		2.80	 			0.009**	
Spleen	mass	(log	transformed)	 	-0.583	 0.500	 	-1.17	 			0.253	
FMuLV	titers	(log	transformed)	by	Virulence	(Spleen	mass)	of	contact	males	
LM;	r2	=	0.398	,	F1,20		=	13.23,	n	=	22	
Fixed	effects	 	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	 0.053	 0.544	 0.10	 		0.924	
Spleen	mass	(log	transformed)	 2.472	 0.680	 	3.63	 		0.002**	
FMuLV	titers	(log	transformed)	by	Virulence	(Spleen	mass)	of	both	contact	sexes	
LM;	r2	=0.421	,	F3,47	=11.4,	n	=	51	
Fixed	effects	 	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	(Female)	 	1.077	 0.397	 	2.71	 		0.009**	
Sex	(Male)	 -0.583	 0.657	 -1.13	 			0.126	
Spleen	mass	(log	transformed)	 -1.024	 0.516	 -1.56	 			0.264	





Table 3S.6.  Summary table of GLMMs of male social status on F-MuLV titer 
and virulence  
F-MuLV	Transmission	to	contact	males	by	social	status	
GLMM	with	binomial	distribution	and	logit	link	(groups:	populations	=	7;	observations	=	14)	
Random	effects	 Variance		 Std.	Deviation	 	
Population	 	0.00	 0.00	
Fixed	effects	 Estimate	 Std.	Error	 Z	value	 Pr(>|z|)	
Intercept	(Nondominant	contact	males)		 	0.17	 0.41	 	0.41	 0.683	
Social	status	(Dominant)	 -0.05	 0.64	 -0.08	 0.938	
Virulence	(Spleen	mass)	of	contact	males	by	social	status	
LMM	(groups:	populations	=	7;	observations	22)	
Random	effects	 Variance		 Std.	Deviation	 	
Population	 	0.00	 0.01	
Fixed	effects	 	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	(Nondominant	contact	males)	 	0.80	 0.09	 	8.94	 <0.0001***	





Random	effects	 Variance		 Std.	Deviation	 	
Population	 	0.08	 0.29	
Fixed	effects	 	 Estimate	 Std.	Error	 t	value	 Pr(>|t|)	
Intercept	(Nondominant	contact	males)	 	1.22	 0.38	 	3.21	 0.007**	















MICROBIAL TRANSPLANT INCREASES  





Many physiological processes in the host are influenced by the microbial 
communities living within the gut. These influences range from digestion of fibrous 
foods to immunity influencing susceptibility to enteric pathogens. Though much work 
has shown a strong relationship with enteric pathogen susceptibility and the microbiome, 
little has been done on how changes in the microbiome influence systemic infection. We 
seek to differentiate between two hypotheses that may lead to changes in FVC virulence: 
(1) that because of trade-offs between resources available for systemic and enteric 
immunity of the host, microbial transfers of the gut microbiota will cause an increase in 
susceptibility to the systemic pathogen Friend Virus Complex (FVC); (2) there will be a 
shift in FVC susceptibility that corresponds with host resistance of the donor 
microbiome. Using established microbial transfer techniques, we reconstituted two 
different treatment groups with different microbiotas: native treatments consisted of hosts 
receiving gut microbiome stock from animals with their same MHC genotype, and novel 
treatments consisted of hosts receiving gut microbiome stock from animals of a different 
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MHC genotype.  Novel treatment groups had higher titer and virulence than the native 
groups, suggesting that the animals in the novel treatment are more susceptible to FVC 
infection. Furthermore, there was a marginally significant reduction in overall 
lymphocyte percentage in the novel treatment group, suggesting animals receiving novel 
microbiomes are potentially immunocompromised; However, there was a significant 
increase in proportion of CD4+ T-cells These results suggest that caution should be taken 
when fecal transplants are done to combat enteric infections as the treatment may cause a 
patient to become more susceptible to other systemic pathogens and that more work 




Gut microbial communities are known to play a role in the maintenance of 
homeostasis and health in the host where specific microbial constituents have been shown 
to aid in digestion of fibrous foods, immunity, and in the ability to detoxify toxins 
(reviewed in Dethlefsen et al., 2007; Sekirov et al., 2010). Colonization immunity, or the 
ability of the microbiome associated with a host to confer resistance to enteric pathogens, 
has implications in human health; leading to a potential therapeutic capacity to combat 
enteric disease (Stecher et al., 2007; Sekirov et al., 2010; Buffie & Pamer, 2013). 
However, it is still unclear to what extent physiological processes can be influenced, 
positively or negatively, by microbiome transfer.  
Microbiomes residing within the host gut have a large influence on host immune 
function and changes in microbial composition of communities alters overall immune 
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function (Maynard et al., 2012). These dynamics are clearly seen in germ-free mouse 
systems where the absence of microbiota leads to severely immunocompromised hosts 
(Cebra, 1999; Khosravi et al., 2014). Microbiome transfers have shown shifts in immune 
function; even the ability to shift susceptibility to enteric pathogens (Willing et al., 2011; 
Kubinak et al., 2015). These immunity shifts have been found to be driven by specific 
immune cell subtypes and differential cytokine signaling that change when interacting 
with novel microbial constituents (Chen et al., 1999; Hensley-McBain et al., 2016). 
Relationships with particular constituents associated with microbial colonization (i.e., 
liposaccharide [LPS]) and increased inflammation have also be found, which may shift 
immunity away from antiviral immunity, allowing viruses to replicate more freely (Pullen 
et al., 1995; Jude et al., 2003). However, the microbiota may be interacting with systemic 
components of the immune system, which may, in turn be influencing interactions with 
systemic pathogens. 
The major histocompatibility complex (MHC) is the key interface involved in the 
differentiation of self from nonself and mediates much of the adaptive immune response. 
It is the most diverse region in the vertebrate genome with over 2,400 alleles for one 
locus in the human population alone (Bodmer et al., 1986; Wegner et al., 2003; Robinson 
et al., 2015). MHC genotypes are highly associated with resistance and susceptibility 
profiles to numerous pathogens (Jeffery & Bangham, 2000). Furthermore, the host MHC 
genotype has a strong influence on shaping the microbial communities in the gut, which 
has been demonstrated using MHC congenic mice (Mus musculus) (Kubinak et al., 
2015). Collectively, the centrality of the MHC in adaptive immunity, its high degree of 
polymorphism, and its proven ability to sculpt microbial communities make MHC 
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congenic mouse lines an ideal model in which to characterize the influence of microbiota 
on systemic pathogen virulence. 
Friend Virus Complex (FVC) is a systemic murine retrovirus that is made up of 
two independent genomes that work synergistically to cause an erythro-proliferative 
disease: Friend Murine Leukemia Virus (F-MuLV) and Spleen Focus Forming (SFFV) 
(Friend, 1957; Ruscetti, 1999). Due to FVC being well characterized and its ability to be 
used as an acute acting virus, it is ideal to use in the short infection study completed here 
(Hasenkrug & Chesebro, 1997; Kubinak et al., 2012, 2013). Previous work with FVC has 
shown increases in virulence in the absence of host microbiota; however, it has not been 
assessed if different microbial communities influence FVC virulence (Mirand & Grace, 
1963). 
Here we test the influence fecal microbial transplants (FMT) have on virulence of 
a systemic pathogen—FVC. We accomplish the FMT by transferring the gut microbial 
constituents of two different strains of MHC congenic mice. Two independent groups 
were created: the novel group received microbiota from the dissimilar MHC genotype 
whereas the native group received microbiota from the same MHC genotype. We seek to 
differentiate between two hypotheses: (1) that transferring gut microbiota between two 
different genotypes of hosts will increase the susceptibility to viral infection by FVC due 
to the tradeoff in immunity, or (2) there will be a shift in susceptibly that corresponds to 







Mice (Mus musculus) were purchased from Jackson laboratories and bred under 
specific pathogen free conditions. Two different strains of MHC congenic Balb/c mice 
were used: BALB/cByJ (Balb/cdd), and C.B10-H2b (Balb/cbb). All animals used in the 
experiment were females between two and six months of age. Twenty-eight animals were 
initially placed on antibiotic treatment before infection and were grouped into four 
treatments (Figure 4.1), two control groups and two treatment groups. Due to severe 
weight loss during antibiotic treatment, seven animals were removed from the study 
before infection leading to 21 total animals being infected.  
All viral stocks were generated from a previously described biological clone of 
the NB-tropic strain of Friend Virus Complex (Kubinak et al., 2012). The viral stock 
used to infect the experimental animals was generated by passaging the biological clone 
through one round of highly susceptible DBA mice in order to produce a virus that was 
virulent enough to cause disease in both host genotypes used in the study. After infection, 
all spleens were collected, mixed in a 1:1 ratio with 1x PBS, homogenized, and 
centrifuged at 5,000 RPM for 5 min. Supernatants were collected, mixed with each other, 
then aliquoted and stored at -80°C. All viral stocks were kept frozen until use and only 
thawed once. 
All infections were intraperitoneal (IP) and were injected at a 20 µL volume. 
After infection, the virus was incubated in vivo for 12 days at which time animals were 
sacrificed. At sacrifice, spleens were harvested and portions were removed and weighed 
for use in flow cytometry. The remainder of each spleen was weighed then homogenized 
in a 1:1 ratio with 1x PBS.  
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To obtain estimates of the number of viral insertions into the host genome, 
quantitative PCR (qPCR) was conducted on F-MuLV using a previously described 
protocol (Kubinak et al., 2012). Due to a strong correlation and previous work showing 
similarities between F-MuLV and SFFV titers only F-MuLV was quantified here 
(Kubinak et al., 2012). Viral titers were standardized to total GAPDH estimates to obtain 
a viral genome by GAPDH ratio. Furthermore, the F-MuLV/GAPD ratios calculated 
previously were multiplied by spleen mass in order to obtain total viral genomes by 
spleen estimates. All qPCR reactions were conducted on a Biorad CFX96 system.  
All microbiota stocks were generated by sacrificing four animals of each MHC 
genotype and collecting microbiota from their intestines (duodenum to anus). The 
microbiome from each genotype was then combined in a 1:1 ratio with 1x PBS in order 
to create the stocks used for oral gavage. All microbiota stocks were spun at 5,000 RPM 
for 5 min., supernatants were aliquoted, flash frozen in liquid nitrogen and then kept at -
80°C until use.  
Animals were treated daily for two weeks with 0.5mg/mL of each of the 
following antibiotics: neomycin sulfate, ampicillin, gentamicin, and erythromycin. 
Following antibiotic treatment mice were put into their respective native or novel groups. 
Native groups consisted of animals receiving a daily oral gavage (100 µL) of microbiota 
from a donor of their own genotype (i.e., Balb/cbb genotype animals received Balb/cbb 
microbiota). Novel groups consisted of animals that received a daily oral gavage (100 
µL) of microbiota from the different host genotype (i.e., Balb/cbb genotype animals 
received Balb/cdd microbiota). Oral gavage occurred daily for one week to allow for 
sufficient reconstitution to occur. One day after the last oral gavage procedure, each 
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animal was infected with a standardized volume of stock FVC.  
Flow Cytometry was conducted at the flow cytometry core at the University of 
Utah using a FACs Canto cytometer running FACsDiva software. All samples were 
isolated from the spleen and run through a 0.22µ filter in order to obtain a single cell 
suspension. Cells were stained per BioLegend cell staining protocol using the following 
conjugated antibody stains: antimouse CD4-FITC, antimouse CD8-PercyPcy5.5, anti-
mouse CD3-Pacific Blue, antimouse CD11a-PE/Cy7, antimouse CD19-PE. These 
conjugated antibodies were chosen to obtain estimates of standing and activated T-cell 
abundance along with standing and activated B-cell abundance. All conjugated antibody 
stains were ordered from BioLegend and used per manufacturer recommendations.   
Linear models were run with host genotype and microbiome treatment groups as 
fixed effects and either spleen mass, proviral load, or spleen corrected proviral load as the 
response variable. These models accounted for variation due to both host genotype and 
microbiome treatment group and their interactions. Post-hoc t-tests were completed when 
a significant interaction term was seen between genotype and treatment group. When 
interaction terms in the linear models were not significant those terms were removed 
from the model as in the titer and spleen corrected titer models. Models were conducted 
with 21 observations each and an intercept set at zero. All statistical analyses were 
conducted on log10 transformed data to improve normality and completed in R statistical 







Novel microbiome caused a significant increase in virulence at the model 
intercept (0.2218 ± 0.0681) when compared to spleen size from animals with native 
microbiomes (LM; t = 3.255, p = 0.005, Table 4.1). There was also a large effect of host 
genotype with the more susceptible genotype (Balb/cdd) having significantly higher 
virulence than the resistant genotype (Balb/cbb) (LM; t = 14.44, p < 0.0001). Furthermore, 
the interaction between host genotype and treatment was also significant (LM; t = -2.177, 
p = 0.045); though post hoc tests indicate the effect is only significant in the Balb/cbb 
genotype (Post hoc Welch T test; Balb/cdd, t = -0.031, p = 0.976; Balb/cbb, t = -3.085, p = 
0.0150) (Figure 4.2A–B). 
Mice with novel microbiomes had marginally significantly increased (0.4922 ± 
0.2339) F-MuLV titers relative to those with native microbiomes (LM; t = 1.75, p = 
0.098). Furthermore, the Balb/cdd genotype showed a significant increase of F-MuLV 
viral titer over the Balb/cbb genotype (LM; t = 4.44, p < 0.001). There was not a 
significant interaction between host genotype and microbiome treatment as both 
genotypes showed an increase in titer in novel treatment, so the interaction term was 
removed from the final model (LM; t = -1.190, p = 0.254) (Figure 4.2C–D). 
The total number of viral genomes per spleen also showed a marginally 
significant increase (0.6646 ± 0.2515) in hosts receiving novel microbiomes over native 
microbiomes (LM; t = 1.92, p = 0.071) (Figure 4.2E–F). Again, host genotype had a 
significant effect on spleen corrected titer with Balb/cdd genotypes having increased 
levels over Balb/bb genotypes (LM; t = 6.84, p < 0.0001). There was no significant 
interaction showing that both genotypes are acting similarly when novel microbiomes are 
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present, so the interaction term was not included in the final model (LM; t = -1.527, p = 
0.1464). 
In novel mice, there was a marginally significant reduction on overall lymphocyte 
proportion (LM: t = -1.90; p = 0.074; Figure 4.3; Table 4.2); however, no other 
significant relationships between tested cell subsets were seen. However, activated CD3+ 
and CD4+ T-cell subsets showed marginally significant and significant (respectively) 
increases in proportion when novel microbiomes were seen (CD3+, LM: t = 1.982, p = 
0.0649; CD4+, LM: t = 2.36, p = 0.031; Figure 4.3; Table 4.2). 
 
4.5 Discussion 
The results presented here support the hypothesis that there may be a tradeoff in 
immunity between systemic and enteric immunity of the host, where the enteric immune 
response is pulling resources away from the systemic response, as we did not see a shift 
in susceptibility corresponding with resistance to FVC as would be expected in 
hypothesis 2. Comparisons between mice receiving either native or novel microbiome 
show an increase in susceptibility, though not significant with each measure, to FVC 
when a novel microbiome is seen; however, the virulence is driven by the significant 
increase in the Balb/cbb genotype. Furthermore, a marginally significant reduction in 
overall lymphocyte proportion was seen in hosts receiving novel microbiomes, 
potentially leaving them less able to fight a systemic pathogen; this result is likely driven 
by a sharp reduction in lymphocytes when Balb/cbb hosts receive Balb/cdd microbiota. 
Although lymphocyte proportion was reduced by a marginal amount, there were 
increases in CD3+ and CD4+ T-cell subsets, again in the mice receiving a novel 
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microbiome. The patterns seen in the lymphocyte, but not the downstream T-cells, 
suggests that there are other important subsets playing a role and need to be determined 
in future work.   
It is thought that cross talk between host and microbiome is important in the 
microbiomes ability to influence disease outcomes of pathogens (Buffie & Pamer, 2013). 
Multiple studies have demonstrated the interconnectivity of the host and microbiome; for 
example, how the Major histocompatibility complex (MHC) shapes the microbial 
community in the gut and how the microbial constituents of the gut influence cytokine 
signaling and immune response outside of the gut (Kubinak et al., 2015). However, little 
work has been completed that has shown an influence of differential communities of 
microbiota on virulence of systemic pathogens.  
Mirand and colleagues in the 1960s used germ free animals to understand the 
effect the microbiome has on FVC virulence (Mirand & Grace, 1963); though they 
showed an increase in virulence in germ-free animals, this may be due to the severely 
immunocompromised nature of germ-free animals as their immune systems never have 
the opportunity to mature (Marietta et al., 2015). Using antibiotic treatment allows us to 
determine the effect of gut microbiota with fully immunologically competent animals. 
Furthermore, other immune responses such as T helper, IL-23, IL-17 and development of 
lymphoid tissue have been correlated with microbiota shifts (Cebra et al., 1998; 
Mazmanian et al., 2005; Zaph et al., 2008). More specifically, T-cell effector cells, such 
as Th17+, Th22 and CD4+ cell, fluctuate in number when rhesus macaques are infected 
with simian immunodeficiency virus (SIV) after the microbiota is perturbed (Hensley-
McBain et al., 2016).  Here we do not see a strong influence on the basic systemic 
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adaptive immune response (i.e. CD4+, CD8+ and B-cells). However, the drastic decrease 
in total lymphocyte proportion suggests there is another cell type that is influencing the 
effect. These data suggest more detailed immune cell phenotyping is warranted and 
perhaps from more tissues than just spleen. 
Due to human health related pathogens, such as causative agents for diarrhea, the 
majority of studies involving microbiota have been done in the context of enteric 
pathogens (Kolling et al., 2012). As a result, specific microbial constituents have been 
found that confer resistance to enteric pathogens, such as Salmonella enterica or 
Clostridium sp. (reviewed in Kamada et al., 2013).  However, these same relationships 
are not known for systemic pathogens. Moreover, the work presented here indicates that 
microbiota transferred between individuals influences the virulence of a systemic 
pathogenic infection. Furthermore, the finding that there is an increase in susceptibility 
when microbiota is transferred between MHC congenic animals, provides further 
evidence that MHC may be influential in shaping the protective nature of the microbial 
community in the gut. The increase in fitness and virulence of FVC may be due to 
multiple physiological responses such as immune resources being taken away from the 
systemic compartment to fight the novel microbiome in the gut or it may also be a change 
in the target cell number present when reconstitution occurs. The latter hypothesis seems 
less likely as data suggest that animals treated with antibiotics have reduced myeloid 
precursor cells suggesting a reduction in target cells for FVC to infect  (Hill et al., 2012; 
Khosravi et al., 2014).  
It has become clear in the last decade that the resident microbiome is acting like 
another organ of the host and that perturbations to that community have rippling effects 
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throughout host physiology, especially on immunity (Rohmer et al., 2011). By treating 
animals with antibiotics then transferring intact microbiomes, we simulate a more 
ecologically relevant situation, as these conditions occur naturally in humans or domestic 
animals when they are prescribed antibiotics for pathogenic bacterial infections or during 
microbial transplant treatment routines (Sullivan et al., 2001; Noverr & Huffnagle, 2004). 
Furthermore, fecal transplants are becoming more accepted and commonplace, especially 
due to the success medical professionals have had in treating Clostridium difficile 
infections with fecal transplants from healthy donors (Bakken et al., 2011; Vrieze et al., 
2013). Though more work is needed to determine the generality of this pattern across 
systemic pathogens; the findings presented here suggest that caution is warranted during 
fecal transfers as treating the enteric disease could make the host more susceptible to a 
systemic viral infection. 
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Figure 4.1. Microbiota transfer experimental design. Microbiota stocks were 
harvested from either Balb/cbb or Balb/cdd hosts. The microbiota stocks were transferred 
into hosts with either the same host genotype (Native) or into host of a different host 




Figure 4.2. Virulence and fitness of FVC in hosts receiving either native or novel 
microbiomes. (A) A significant increase in virulence was seen in novel (open symbols) 
over the native (filled symbols) treatment, however, there is also a significant interaction 
suggesting the two genotypes are responding differently. Due to the significant 
interaction in virulence post hoc t-tests were performed which showed the effect of the 
LM is driven by the Balb/cbb genotype (square symbols). (B) Proviral load showed a 
marginally significant increase in hosts receiving novel microbiomes. (C) Furthermore, 
spleen corrected titer also showed a marginally significant increase in the novel group 






Figure 4.3. Immune cell subset proportions of total cells or total lymphocytes. (A) 
Total lymphocyte proportion of total cells counted, showing a reduction in proportion in 
novel treatment groups when compared to native treatment groups. (B) CD3+ (T-
lymphocytes) proportion of total lymphocyte population. There was a marginally 
significant increase in CD3+ T-cells in novel treatment groups over native treatment 
groups. However, this increase is driven by (C) CD4+ T-cells having a significant 
increase in novel treatment groups. Symbols denote genotype with filled symbols 
indicating native treatemtn group and open symbols indicating novel treatments. Data are 




Table 4.1. Linear models comparing treatment groups (native and novel), and 
host genotype. 
Virulence (Spleen mass) of treatment groups 
LM (F3,16 = 125.9; R2 = 0.9594;  p-value = 2.44e-11) 
Fixed Effects Estimate Std. Error t value Pr(>|t|) 
Intercept (Native Microbiota) -0.6956 0.0503 -13.823 2.59e-10 *** 
Host (Balb/cdd)  1.0899      0.0755     14.438 1.35e-10 *** 
Treatment (Novel Microbiota)  0.2218      0.0681     3.255    0.00497 *   
Interaction (Balb/cdd:Novel) -0.2214     0.1017   -2.177    0.04480 *     
F-MuLV titers (log transformed) of treatment groups. 
LM (F3,16 = 8.551; R2 = 0.6159;  p-value = 0.00128) 
Fixed Effects Estimate Std. Error t value Pr(>|t|) 
Intercept (Native Microbiota) -2.6409 0.2593 -10.186 1.18e-08 *** 
Host (Balb/cdd) 1.3328     0.2999     4.444 0.00037 ** 
Treatment (Novel Microbiota) 0.5247      0.2999     1.750    0.0982 .   
Spleen Corrected F-MuLV titers (log transformed) of treatment groups. 
LM (F3,17 = 25.35; R2 =  0.7193;  p-value < 0.0001)   
Fixed Effects Estimate Std. Error t value Pr(>|t|) 
Intercept (Native Microbiota) -3.2825 0.2910 -11.280 2.58e-09 *** 
Host (Balb/cdd)  2.3009      0.3366     6.836 2.90e-05 *** 
Treatment (Novel Microbiota)  0.6473      0.3366     1.923    0.0714 .   




Table 4.2. Linear models comparing treatment groups (native and novel), and host 
genotype of Total immune cell subsets. 
Total Lymphocyte proportion by treatment groups 
LM (F2,17 = 4.127; R2 = 0.2476;  p-value = 0.035) 
Fixed Effects Estimate Std. Error t value Pr(>|t|) 
Intercept (Native Microbiota) 0.3694 0.0476 7.754 5.57e-07 *** 
Host (Balb/cdd) -0.1176      0.0551    -2.135 0.047 * 
Treatment (Novel Microbiota)  -0.1047      0.0551    -2.901    0.074 .   
Total Activated CD3+ proportion by treatment group 
LM (F2,17 = 1.93; R2 = 0.089;  p-value = 0.176) 
Fixed Effects Estimate Std. Error t value Pr(>|t|) 
Intercept (Native Microbiota) 0.128 0.0240 5.341 5.4e-05 *** 
Host (Balb/cdd) -0.005 0.0278    -0.163 0.872 
Treatment (Novel Microbiota) 0.054      0.0278    1.960    0.067 .    
Total Activated CD4+ proportion by treatment group 
LM (F2,17 = 10.59; R2 =  0.5023;  p-value = 0.001)   
Fixed Effects Estimate Std. Error t value Pr(>|t|) 
Intercept (Native Microbiota) 0.086 0.0259 3.312 0.0041 ** 
Host (Balb/cdd)  0.118      0.0301     3.928 0.0011 ** 
Treatment (Novel Microbiota)  0.071      0.0301     2.356    0.0307 *  
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Animals heterozygous at the major histocompatibility complex (MHC) are 
thought to be more protected against pathogens as they have the potential to recognize 
twice the pathogenic peptide as homozygotes (Kubinak et al., 2012a). Furthermore, it has 
been shown that vertebrates increase the MHC heterozygosity of their offspring through 
disassortative mating preferences, suggesting heterozygosity is beneficial in natural 
populations (Penn & Potts, 1999; Mays & Hill, 2004). However, heterozygosity is not 
universally protective against pathogens, as there are MHC alleles that have dominate 
susceptibility profiles; this has been shown in salmonella and Theiler’s virus where some 
heterozygote combinations are more susceptible to the pathogens than either of the 
homozygotes, though when both pathogens are coinfected together the heterozygote 
genotypes seem to be protective relative to the homozygotes (McClelland et al., 2003).  
Here we use Friend Virus Complex (FVC) to test whether MHC heterozygote 
animals are more resistant to the pathogen than MHC homozygote animals through serial 
passage, we would expect that if there was an advantage to being an MHC heterozygote, 
heterozygote animals lower virulence and viral titer in the MHC homozygote animals. 
Furthermore, if MHC heterozygotes are more difficult for FVC to adapt to, then we 
would hypothesize that homozygote passage would increase in fitness and virulence more 
rapidly, as has been shown previously, whereas heterozygote passages will take a higher 







Ten animals of each MHC genotype were infected in order to understand how 
virulent the virus is during the initial infection: Balb/cdd, Balb/cbb, Balb/ckk, Balb/cdk, and 
Balb/cbd. The second and third rounds consisted of five animals of each genotype due to 
constraints in animal number.  FVC was serial passaged through each genotype three 
times to further test whether the virus has a more difficult time adapting to heterozygote 
animals than homozygote animals. Animals were sacrificed 12 days postinfection at 
which time spleen mass (virulence) was measured. After measurement, the spleens were 
mixed in a 1:1 ratio with 1x Phosphate Buffered Saline (PBS), homogenized and spun at 
5000 RPM. Supernatants were collect and frozen at -80°C until thawed to infect the next 
round of animals. DNA was extracted from spleen homogenates and qPCR was done in 
order to determine the number of proviral insertions occurred which is a measure of viral 
titer (fitness).  
 
C.3 Results and Discussion 
 After the first 12 day infection there was no heterozygote advantage seen as each 
of the homozygote genotypes tested had significantly reduced virulence than their 
heterozygote counterparts; however, heterozygotes did not show a significant decrease in 
viral fitness (LMM; Virulence, t = -2.42, p = 0.019; Fitness, t = -3.59, p = 0.19; Fig C1A-
B).  Furthermore, this disadvantage continued into the second round of serial passage, 
with virulence still showing an increase in heterozygotes over homozygotes (LMM; 
Round 2, t = -2.34, p = 0.029; Fig C2A); though the effect was lost in the third round 
where there was no significant difference in virulence between the two treatment groups 
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(LMM; t = -1.11, p = 0.382; Fig C2B).  
 Here we show that there is an overall disadvantage to being an MHC heterozygote 
when infected with FVC, though this disadvantage disappears through passage of the 
virus. The lack of increase through serial passage in homozygote animals has not been 
seen before as previously each time FVC has been serially passaged through these MHC 
homozygote genotypes there has been a dramatic increase in both fitness and virulence, 
which we do not see here (Kubinak et al., 2012b, 2013, 2015). Regardless of the lack of 
increase through passage there was still an initial disadvantage in heterozygote animals; 
however, more work needs to be completed to determine if the heterozygote disadvantage 
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Figure C.1. Spleen mass and proviral estimates by treatment group in round 1 
passages. (A) Heterozygotes had significantly higher spleen masses than homozygotes in 
the initial round of infection; (B) whereas there was no difference detected in viral titer. 











Figure C.2. Virulence estimates in the second and third round of infections. (A) The 
heterozygote disadvantage persisted into the second round as heterozygotes had 
significantly larger spleens than homozygotes. (B) In the third round there was no 
detectable difference in spleen mass. Data represented by mean ± SE. 
 
